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Abstract 
Background: Insomnia is a disorder of sleep characterised by difficulty initiating sleep, 
maintaining sleep, waking too early or sleep that is non-restorative or poor in quality. 
The absence of a clear consensus as to how insomnia should be conceptualised and 
defined has hampered diagnosis and treatment in both clinical and research settings. This 
has led to inconsistent research findings and limited comparability of outcomes across 
studies. In addition, despite phenotypic differences in the characteristics and treatment 
responses of different insomnia subtypes they are usually managed by clinicians in the 
same way. In 2004 the American Academy of Sleep Medicine (AASM) sought to 
address these issues with the publication of standardised Research Diagnostic Criteria 
(RDC) for Insomnia and recommendations for assessment procedures and information 
reporting. The current review aimed to identify the extent to which the RDC and 
associated recommendations have impacted on research into psychological treatments 
for insomnia since they were published in late 2004. Methods: Studies were identified 
by searching electronic databases, hand searching key journals and reviewing reference 
sections of relevant publications. Those studies which incorporated a randomized design 
and included adult participants with primary insomnia, who received a cognitive 
behavioural intervention for insomnia, were selected for review. These studies were 
rated according to: diagnostic criteria used to define their samples; methods of 
assessment employed; and reporting of descriptive and quantitative information relating 
to sample recruitment and characteristics. Results: Six studies were reviewed of which 
only one specifically employed the recommended RDC for Insomnia Disorder and 
Primary insomnia, although three reported criteria that corresponded to the universal 
RDC for Insomnia Disorder. None of the studies differentiated between primary 
insomnia subtypes. The results with regards to assessment procedures and information 
reporting were also disappointing with no study meeting the recommendations of the 
AASM. Conclusions: It was concluded that on the basis of the studies reviewed, the 
recommendations of the AASM have had only a minimal impact on research into 
psychological interventions for insomnia. 
 
Keywords: insomnia, research diagnostic criteria, psychological intervention, cognitive 
behavioural therapy for insomnia. 
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Introduction 
 
Insomnia is a disorder of sleep that is characterised by complaints of difficulty in 
initiating sleep and/or maintaining sleep, waking too early or sleep that is non-restorative 
or poor in quality. 1 It is one of the most prevalent health problems worldwide with 
around one third of the adult population experiencing insomnia symptoms and between 
9% and 12% having persistent difficulties with sleeping. 2 Chronic insomnia can lead to 
impaired occupational performance and reduced quality of life and is seen as a major 
public health concern, not least because of the significant costs associated with assessing 
and treating the condition. 3,4 Despite our knowledge of insomnia and how it might best 
be managed seeing some considerable advances in recent years, it remains a poorly 
understood condition that is inadequately identified and treated and is often viewed by 
clinicians as merely a symptom of other so-called ‘primary’ medical or psychiatric 
disorders. 5 In addition, despite phenotypic differences in the characteristics and 
treatment responses of different insomnia subtypes they are usually managed by 
clinicians in the same way. 
 
Unfortunately, lack of a clear consensus as to how insomnia should be conceptualised 
and defined has long hampered diagnosis and treatment in both clinical and research 
settings. 5-7 On the one hand, people with insomnia tend to report broadly similar 
experiences with regard to sleep disturbance and how it can impact on their daytime 
functioning and this led to the development of some relatively broad and simple 
definitions of insomnia. However, there can also be significant variation in terms of 
peoples’ descriptions of the severity and duration of their insomnia and how it has 
developed over time. This suggests that insomnia is perhaps a more complex and 
heterogeneous disorder than that depicted by broad definitions and has driven the 
development of alternative descriptions of insomnia that acknowledge these phenotypic 
differences. 
 
These different approaches to conceptualising insomnia are reflected within the current 
main diagnostic schedules that include criteria relating to sleep disorders, namely the 
Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV) 8 and the 
International Classification of Sleep Disorders, 2nd Edition (ICSD-2) (1). DSM-IV 
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adopts an inclusive approach with four major categories for insomnia diagnoses 
including Primary Insomnia (See Table 1) which includes all persons reporting 
difficulties associated with initiating or maintaining sleep for at least one month that are 
not related to other diagnosable medical or psychiatric disorders. This broad approach to 
diagnosing insomnia has been criticised by specialist sleep researchers and clinicians as 
it groups together people with widely differing insomnia complaints. 7 By contrast the 
ICSD-2 provides a more comprehensive classification system where insomnia 
complaints of a primary nature can be split into different insomnia subtypes, as 
presented in Table 1, and overall includes approximately 40 categories of sleep disorder 
that can have insomnia as a prominent complaint. There has been much debate over the 
years regarding the utility of insomnia subtypes, however, most sleep specialists would 
argue that they are crucial to the continuing development of our understanding of 
insomnia, and to the design of useful diagnostic tools and effective treatments protocols. 
2,6,7
 
 
(INSERT TABLE 1 HERE) 
 
The absence of clear standard definitions for insomnia has led to the employment of 
widely differing inclusion and exclusion criteria across the research literature and thus 
has limited comparability of outcomes between studies. 5,9 This has had implications for 
epidemiological studies and those investigating the characteristics and pathophysiology 
of insomnia but has perhaps had most important relevance to treatment research and in 
turn helping clinicians make decisions about appropriate interventions for patients. In 
clinical research the criteria employed to define insomnia can vary greatly from being 
liberal and merely requiring the presence of a sleep disturbance, to strictly requiring 
participants to meet all the criteria for insomnia as laid out in one of the main diagnostic 
schedules. The assessment procedures that are used to ascertain whether subjects meet 
study criteria also vary considerably and can often be levied as a potential 
methodological limitation or weakness of insomnia studies. 9 It should also be noted that 
although the terms primary insomnia and psychophysiological insomnia in fact refer to 
two differing insomnia definitions, they are frequently used interchangeably in the sleep 
literature to describe people with a chronic insomnia complaint that is primary rather 
than secondary to another condition. 
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In order to try and address the issues around insomnia diagnosis and classification, and 
recognising the positive impact that the development and use of Research Diagnostic 
Criteria (RDC) had previously had in other areas of psychiatric research and practice, 
10,11
 the American Academy of Sleep Medicine (AASM) formed an Insomnia RDC Task 
Force to oversee the development of standard definitions for currently recognized 
insomnia disorders. The Task Force appointed an RDC Work Group (RWG) to carry out 
the tasks required to meet the three primary objectives/aims of the RDC project which 
were to: 1) Review the insomnia literature and determine which of the current insomnia 
diagnoses appear most reliable and valid regardless of the diagnostic nosology in which 
they originally appeared; 2) Derive standard RDC for defining each of the subset of 
insomnia diagnoses that have the greatest empirical and consensual support; and 3) 
Propose specific assessment methods/procedures for identifying the presence/absence of 
the RDC among the patients and study participants to which they are applied. 9 
 
The findings of the RWG’s review were published in late 2004 9 and included 
recommended universal RDC for insomnia, for use by all researchers regardless of the 
insomnia subtype in question, and RDC for a range of specific insomnia subtypes 
including Primary Insomnia, Psychophysiological Insomnia, Idiopathic Insomnia and 
Paradoxical Insomnia. These RDC incorporated elements of both DSM-IV and ICSD-2 
criteria and sought to reinforce the importance of recognizing these subtypes in research 
and clinical practice. The RWG’s report also laid out specific recommendations for 
methods of assessment that should be utilised by researchers to ascertain relevant RDC 
when recruiting study samples. These included the use of clinical interviews, 
polysomnography (PSG), and sleep diaries/logs. In addition, in order to assist with 
ongoing revisions of the RDC, the RWG also made recommendations regarding the 
types of descriptive information that researchers should consistently report in their 
published studies. Researchers were also encouraged to assign applicable ICSD 
insomnia subtype diagnoses to study participants who meet RDC for primary insomnia 
as this would help determine the utility of ICSD subtypes over the more global primary 
insomnia diagnosis. 
 
The RWG hoped that their recommendations would be seen as a starting point for 
improving insomnia research and would discourage further studies of poorly 
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characterized insomnia samples that give little insight into the pathology and treatment 
needs of specific insomnia subtypes. It was also thought that the RDC could help 
standardise insomnia research and enable much needed reliability and validity studies to 
be carried out in future. 9 Given that a number of years have passed since the publication 
of the RWG’s findings and recommendations, we felt that it may be timely to review the 
extent to which they have impacted on insomnia research, with a specific focus on 
research into psychological interventions for insomnia. Accordingly, the present review 
aimed to address the following: 
 
Aim: 
To identify the extent to which the recommendations of the RWG have impacted on 
research into psychological treatments for insomnia since they were published in late 
2004. 
 
The review aimed to address the following specific questions: 
 
Primary Questions 
 
1. Which diagnostic criteria have researchers utilised to define and describe their 
participant samples and do they correspond to the criteria recommended by the 
RWG? 
 
2. Have researchers employed the assessment methods recommended by the RWG to 
ascertain whether participants meet the diagnostic criteria employed? 
 
3. Have researchers reported the descriptive and quantitative information relating to 
sample recruitment and characteristics that the RWG recommended they should 
report? 
 
Secondary Question 
 
4. How do the treatment outcomes of the reviewed studies compare to those found by 
previous reviews and meta-analyses of research into psychological interventions for 
insomnia published prior to publication of the RDC for insomnia? 
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Methods 
 
 
Search Methods, Keywords, and Databases 
 
The following electronic databases were searched by the author: 
 
• The Cochrane Library: 2005 to January 2010 
• Ovid Medline: 2005 to January 2010 
• EMBASE: 2005 to January 2010 
• PsycINFO: 2005 to January 2010 
 
Duplicates were removed and searches were limited to the English language. The 
electronic search was supplemented by searching the reference sections of included 
papers as well as those of other review papers and meta-analyses published during the 
period 2005 to January 2010. 
 
The following terms were used to search the databases: ‘sleep initiation and maintenance 
disorders’; ‘insomnia’; ‘psychological therapy’; ‘behav* therapy’; ‘cognitive therapy’; 
‘cognitive behav* therapy’; ‘pharmaco*’; ‘randomi* contro* trial’; ‘random allocation’. 
The results of these searches were combined where appropriate using AND. 
 
Selection Criteria 
 
Articles identified by the search strategies employed were screened for relevance using 
the following criteria: 
 
Inclusion Criteria 
 
• Studies incorporating a randomised design and that include a group who received 
a cognitive behavioural intervention for insomnia 
• Participants included should have a primary insomnia disorder 
• Studies of adult participants age 18 years and over 
 
Exclusion Criteria 
 
• Studies that do not incorporate a randomised design 
• Studies including participants with secondary or comorbid insomnia 
• Studies where participants were under 18 years of age 
 
Search Results 
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The search of electronic databases yielded 335 potentially relevant articles after 
duplicates were removed. A flowchart of the study selection process is presented in 
Figure 1. Titles and abstracts were examined by the author and 15 studies of potential 
relevance were identified and retrieved in full text form. 9 of these were excluded after 
screening as the studies had commenced prior to the publication of the RWG’s 
recommendations. With regard to the study by Wu and colleagues, 15 it refers to the 
original ICSD from 1990, 16 and not ICSD-2 and included an 8 month follow-up period. 
As such it appears likely that this study too was conceived and conducted prior to the 
publication of the RDC for insomnia. However, there is no reference within the 
published article as to when the data were collected or the manuscript submitted for 
publication and so it was thought appropriate for inclusion in the review. 
 
(INSERT FIGURE 1 HERE) 
 
Study Evaluation 
All studies that met criteria for inclusion in the review were evaluated using an 
idiosyncratic tool developed by the researcher (see Appendix A.2). This was based on 
the various recommendations made by the RWG and was designed to assess the 
following: 
 
• Which diagnostic criteria for insomnia were employed by the researchers? 
• Did the criteria employed correspond to the RDC for Insomnia Disorder/Primary 
Insomnia? 
• Were relevant insomnia subtypes identified and differentiated between? 
• Were participants further categorised according to the pattern of their insomnia 
problem, for example, having sleep onset or waking after sleep difficulties? 
• Which assessment procedures were employed to identify participants who met 
the criteria employed? 
• Did the researchers report information about recruitment methods descriptive 
statistics relating to sleep measures and sample characteristics as recommended 
by the RWG? 
 
The evaluation tool included eleven items relating to two subscales for Assessment 
procedure (5 items) and Information reporting (6 items). Each subscale had a maximum 
score of 12 points thus allowing each study a possible total score of 24 points. The study 
evaluation process was completed by the author and an independent rater whom was a 
qualified Clinical Psychologist who did not have an extensive knowledge of insomnia 
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research.  Disagreements about ratings were minimal and were resolved through 
discussion until agreement was achieved. 
 
With regard to evaluating the diagnostic criteria employed, it was assumed that where a 
study made reference to one of the existing diagnostic systems, such as DSM-IV or 
ICSD-2, that all of the criteria these encompass were adhered to even if they were not 
specifically detailed within the study text. Any additional criteria listed were also taken 
into account when judging whether or not the criteria employed within a study met the 
RDC for Insomnia, Primary Insomnia or a primary insomnia subtype. 
 
In order to evaluate the treatment outcomes reported in the studies effect sizes were 
calculated to indicate the magnitude of the differences between groups on the primary 
outcome measures adopted in each study. Effect sizes were calculated as Cohen’s d, 17 
and were based on reported group means and pooled standard deviations for the 
psychological treatment groups and relevant control or placebo groups in each study. 
This was with the exception of the study by Zavesicka and colleagues, 24 which 
incorporated a clinical comparison group that received CBTi plus medication. 
 
 
Results 
 
Description of the Studies and Samples 
Table 2 summarises the main features of the 6 studies selected for inclusion in this 
review. 15, 21, 24-27 For each study it shows; the sample size, insomnia diagnosis, 
diagnostic criteria employed, assessment procedures used, treatment type, treatment 
duration, longest follow-up period, outcome measures employed, and a summary of the 
main findings. The main sleep diagnoses used to describe the study samples were 
chronic and/or primary insomnia. A total of 548 participants took part in the studies with 
284 receiving a psychological treatment intervention for insomnia either singly (n = 256) 
or in combination with medication (n = 28). For the purposes of comparison with the 
psychological intervention groups half of the studies incorporated a waiting list control 
group, two had placebo groups of which one was a placebo medication,15 and the other a 
sham biofeedback treatment,21 and two others compared CBTi with CBTi plus 
medication. 15, 24 
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Five of the studies employed a form of CBTi as a treatment intervention.15, 24-27 The 
remaining study claimed to employ a CBTi intervention but the treatment components 
listed were all behavioural and did not include cognitive therapy.21 The most commonly 
employed treatment components were Stimulus Control (n = 6), Sleep Hygiene 
Education (n = 6), Cognitive Therapy (n = 5), Sleep Restriction (n = 5) and Relaxation 
(n = 3). The majority of studies (n = 5) relied on sleep diary data as a primary outcome 
measure and 2 also utilised PSG data. Primary dependent variables derived from these 
assessment methods were sleep onset latency (SOL) (n = 6), total sleep time (TST) (n = 
5), sleep efficiency (SE) (n = 5), wake time after sleep onset (WASO) (n = 4), sleep 
quality (SQ) (n = 3) and number of nocturnal awakenings (NWAK) (n = 2). Three 
studies included insomnia severity ratings as a primary outcome variable.24, 26, 27 
Secondary outcomes included measures of insomnia severity, sleep quality, beliefs and 
attitudes about sleep and pre-sleep arousal. Half of the studies collected follow-up data 
with the follow-up periods ranging from 4 weeks to 8 months. 15, 26, 27 
 
Evaluation of the Diagnostic Criteria Employed 
All of the studies reviewed provided details of the criteria that had been used to identify 
participants with insomnia. Table 2 shows that all but one of the studies made specific 
reference to one of the existing nosologies for insomnia diagnosis. Three studies made 
use of either DSM-IV or DSM-IV-TR criteria, 15, 24,26 with one of these also using ICSD 
criteria. 15 One study incorporated ICSD-2 criteria,21 and only one of those reviewed 
explicitly employed the RDC for Insomnia Disorder as recommended by the RWG.27 In 
addition to referring to the diagnostic systems that had guided the criteria employed, five 
of the studies listed additional idiosyncratic inclusion and/or exclusion criteria that had 
been used to assess potential participants.15,21,24,26,27 
 
Three of the studies reviewed reported criteria that correspond to the RDC for Insomnia 
Disorder, 21, 26, 27 with one of these meeting both the RDC for Insomnia Disorder and 
Primary Insomnia.27 The other three studies only partially met these criteria,15, 24, 25 with 
two not making specific reference to criterion B of the RDC for Insomnia Disorder 
which refers to establishing that the sleep difficulties reported occur despite adequate 
opportunity and circumstances for sleep.15, 24 The remaining study met only criterion A 
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which refers to individuals reporting difficulty initiating or maintaining sleep.25 Indeed it 
could be argued that this study should not have been included in the review due to the 
minimal inclusion criteria it employed. However, as the study authors’ had outlined the 
study as an examination of an intervention for insomnia and drew conclusions about the 
efficacy of the treatment in relation to insomnia, it was felt that a case could be made for 
including the study in the current review. 
 
Evaluation of the Assessment Procedures Employed 
Each of the studies reviewed outlined details of the assessment methods employed to 
ascertain whether potential participants met the stated inclusion criteria. Table 2 shows 
the type of assessment procedures used by each study. The majority of the studies 
included clinical interviews (n = 5) and sleep diaries (n = 4) in their assessment 
procedures and two recorded PSG data to validate participant inclusion.21,24 Those two 
studies also made use of self-report questionnaires relating to aspects of sleep and 
psychological well-being in order to assess inclusion and exclusion criteria. 
 
Table 3 shows the ratings for each of the studies on the items in the evaluation tool that 
relate to the assessment procedures they reported. Total assessment procedure rating 
scores for the studies ranged from 0 to 8 points with no study incorporating all of the 
assessment procedures recommended by the RWG. It can be seen from Table 3 that 
whilst five of the studies conducted clinical interviews with participants,15,21,24,26,27 only 
one indicated that independent interviewers had been used and it did not assess inter-
rater reliability.15 Two of the studies assessed potential participants using PSG data. Of 
note, one study collected PSG data at baseline/pre-treatment but did not report collecting 
it in the initial assessment process. 15 In addition, no information was reported to 
indicate whether or not any potential participants were excluded as a result of the PSG 
data recorded at baseline. 
 
Evaluation of the Descriptive Information Reported 
Each of the studies were rated on the information they reported with regard to their 
recruitment methods and descriptive data relating to sleep variables and sample 
characteristics. Table 3 includes the rating scores for each of the studies and shows that 
the total information reporting scores ranged from 6 to 12 points with only one study 
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reporting all of the information recommended by the RWG.26 Four of the studies 
provided clear information on the procedures through which participants were actually 
recruited,21, 24, 26, 27 and every study indicated whether participants had been clinical or 
volunteer type participants. All of the studies reported appropriate descriptive data on 
the sleep measures they employed but the picture in relation to insomnia duration and 
frequency was poorer with only three studies reporting data for duration, 24-26 and just 
one reporting frequency data.26 None of the studies which collected both objective and 
subjective measures of sleep reported data on discrepancies between subjective and 
objective measures of sleep variables. 
 
Treatment Outcomes 
As a secondary area of enquiry for the current review each of the studies was reviewed 
in relation to reported treatment outcomes. The main findings are summarised in Table 2 
and shall not be repeated here. Effect sizes were calculated for each of the studies on 
reported sleep parameters at post-treatment and these data are presented in Table 4. 
 
It can be seen from Table 4 that all of the studies achieved either medium or large effect 
sizes on SOL with the exception of one that did not find significant between group 
differences on any of the sleep parameters measured.25 Two of the three studies which 
measured WASO as a primary outcome measure found medium effect sizes,21,24 whilst 
the other study did not find any differences on this measure.27 Only two studies reported 
data relating to NWAK but each found differences that equated to medium effect 
sizes.26,27  The two studies which used PSG as an outcome measure achieved medium to 
large effect sizes on TST,15,24 whilst two that used subjective measures reported only 
small effect sizes on this sleep variable.26,27 With regard to SE, three of the studies found 
differences which correspond to large effect sizes,21,24,26 and two others found small 
effect sizes.15,27 Table 2 shows that all three of the studies which incorporated a follow-
up period reported that the gains found in their CBTi groups at post-treatment had 
largely been maintained at follow-up.15, 26, 27 
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Discussion 
 
A systematic review of six studies was conducted to assess the extent to which the 
recommendations of the American Academy of Sleep Medicine’s Research Diagnostic 
Criteria Work Group 9 have impacted on research into psychological treatments for 
insomnia since they were published in late 2004. Specifically, the review aimed to 
identify whether researchers had implemented the diagnostic criteria, assessment 
methods and information reporting practices recommended by the RWG. 
 
With regard to the first of these areas, the results indicate that whilst most of the studies 
reviewed made use of existing diagnostic schedules for insomnia diagnosis, only one 
made reference to and incorporated the recommended RDC for Primary Insomnia and 
only two other studies employed criteria that were considered to correspond to the 
universal RDC for Insomnia Disorder. The broadly inclusive DSM-IV criteria for 
primary insomnia were the most commonly employed and there was no reference in any 
of the studies to primary insomnia subtypes or using these to differentiate amongst 
participants. There was also common use of idiosyncratic additional inclusion and 
exclusion criteria across the studies and this when combined with the use of the different 
diagnostic schedules meant that no two studies employed identical criteria to define their 
samples even though they were largely purporting to be studying participants with the 
same type of sleep complaint. Overall, the findings with regard to the use of appropriate 
diagnostic criteria and identification of insomnia subtypes among samples of people 
with primary insomnia, suggest that the recommendations of the RWG have had only a 
minimal impact thus far. 
 
The results in relation to the second area of enquiry were similarly varied with wide use 
of clinical interviews and sleep diaries to assess potential participants but no study 
incorporating all of the various assessment procedures recommended by the RWG. In 
addition, there was little indication that independent interviewers or techniques for 
monitoring interviewer reliability had been employed in the studies reviewed. Only two 
studies made use of PSG data to screen potential participants and it may be that this is 
due to the fact that this is a method of assessment that is time consuming, impractical in 
terms of available resources and organisational requirements and relatively costly to 
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employ. Again these findings suggest that as yet the recommendations of the RWG have 
not had a noticeable effect on this area of insomnia research. 
 
The level of descriptive information relating to sample recruitment and characteristics 
reported within the reviewed studies might also be seen as disappointing with only one 
study reporting all of the information recommended by the RWG and another falling just 
short of this. Encouragingly all of the studies reported appropriate descriptive data on 
the measures they employed but the lack of data on insomnia duration and frequency 
reflects the lack of attention to the inclusion of participants with different insomnia 
subtypes. This is an important omission by the researchers as duration and frequency of 
insomnia is a key factor in distinguishing between Idiopathic Insomnia (IdI) and 
Psychophysiological Insomnia (PI) which are quite different in phenotype and thought to 
respond differently to psychological treatments. As such the inclusion of people with IdI 
in investigations of CBTi will potentially have a negative affect on outcomes. Similarly, 
it is not clear from the details reported whether those who may have had Paradoxical 
Insomnia were screened for and excluded from the studies reviewed. Generally the 
findings from this section of the review would also indicate that the recommendations of 
the RWG have yet to make the desired impact on the research literature. 
 
Comparison of treatment outcomes 
The secondary aim of the current review was to compare the reported treatment 
outcomes with those found by previously published reviews and meta-analyses of 
psychological interventions for insomnia. However, as the current review unexpectedly 
includes a much smaller number of studies than had been expected this limits the 
validity of such a comparison. Secondly, the effect sizes reported by the studies in the 
current review are highly variable across each of the sleep parameters measured and this 
too makes comparison both difficult and limited in terms of its validity. Any comparison 
is further complicated by the variability in the outcome measures employed and the 
mixture of CBTi components that were delivered across different studies and also the 
mode via which they were delivered i.e. by a clinician, self-help material or via the 
internet or television. Consequently, and in view of the fact that this was a secondary 
aim of the current review, it is perhaps appropriate to make only a general comparison 
between the main outcomes reported and previous review findings. A recently published 
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review of the evidence for treatments of chronic insomnia provides an appropriate and 
convenient comparison.29 This paper sought to provide a comprehensive assessment of 
the efficacy of both benzodiazepine receptor agonists (BZRAs) and psychological 
interventions for insomnia and is based on all relevant meta-analyses and randomised 
controlled trials published up to 2006. Of note, this paper reviewed one of the studies 
that is also included in the current review.15 
 
The results of the current review show that although there was notable variation in 
outcomes, several of the studies found CBTi to be effective in achieving medium to 
large effect sizes across the variables measured. In addition, the studies that incorporated 
a follow-up period all reported that these gains were largely maintained at follow-up. 
This is in line with the findings of Riemann and Perlis’ 29 review which concluded that it 
was clear that patients derive benefits from psychological interventions for insomnia in 
both the short and long-term and that gains achieved via this mode of treatment can even 
appear to increase over time. They also found evidence that strongly suggested that 
BZRAs and psychological interventions are comparably effective during periods of 
active treatment but that CBTi can confer longer lasting benefits. This is reflected by the 
findings of studies in the current review that compared CBTi with medication. Overall, it 
could be said that although highly variable, the treatment outcomes reported by the 
studies in the current review are broadly in line with that found previously in the 
insomnia treatment literature. 
 
Limitations 
The main limitation of this review is the unexpectedly small number of studies it 
includes. This was due to a lack of appropriate studies being published since 2005 and 
this perhaps reflects the length of time and level of effort that it takes to get randomised 
studies through from conceptualization and design to completion and publication. This is 
evidenced by the number of studies that were published within the five years since the 
RWG’s recommendations but had to be excluded due to their data collection having 
commenced before 2005. Accordingly, it may be that the timing of this review was 
somewhat premature and were it to be repeated in a few years time a different picture 
might emerge. Had the review employed broader inclusion criteria, including non-
randomised study designs, this too may have resulted in different findings. 
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Conclusions and implications 
Despite the limitations of the current review, the fact that only one of the studies 
reviewed made any reference to the recommended RDC and none made use of insomnia 
subtypes must be seen as concerning. Likewise, with regard to the overall aim of the 
current review, it would seem reasonable to conclude that on the basis of the studies 
reviewed, the recommendations of the AASM’s RWG have had only a minimal impact 
on research into psychological interventions for insomnia. This could be seen as an 
indication that the RWG’s hopes that their recommendations would be seen as a starting 
point for improving insomnia research, and would discourage further studies of poorly 
characterized insomnia samples, have not been met with a positive response from 
insomnia researchers. Indeed, the findings would suggest that research into 
psychological interventions for insomnia may continue to be dogged by issues of 
validity and comparability in the future due to the ongoing lack of the use of 
standardised definitions, diagnostic criteria and assessment procedures. It can clearly be 
seen from even the small number of studies reviewed here that the failure to make use of 
these is associated with significant variability in treatment outcomes and the inability to 
make any meaningful comparisons between different studies. 
 
The issue of researchers not differentiating between different insomnia subtypes is also 
in this author’s mind a particularly important one as the research evidence about the 
effectiveness of treatments for insomnia will continue to be questionable if researchers 
continue to ignore the fact that they are likely recruiting participants who suffer from 
variants of insomnia that are quite different in terms of their characteristics and response 
to psychological treatments. This of course also has implications for clinical practice as 
unless robust research is carried out to clearly validate these insomnia subtypes, 
clinicians will continue to manage many patients’ insomnia complaints from a largely 
misinformed viewpoint and will be unable to provide them with advice and interventions 
that will be helpful to them. 
 
Recommendations 
In light of the above issues and given the apparent ongoing wide use of different 
diagnostic schedules, definitions of insomnia and methods for assessing these, it would 
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perhaps be useful if a standardised procedural checklist were to be devised to guide 
researchers in appropriate insomnia diagnosis and research protocols. This could 
incorporate the recommendations of the RWG and other relevant information and could 
be referred to easily in research articles as having guided researchers in devising and 
conducting their studies. If it were freely available and easily accessible via the internet 
this might also encourage its use. Incorporating something like this, or reference to its 
availability, within future revisions of the main diagnostic nosologies could also be 
helpful to researchers and clinicians alike. In time this would hopefully help to address 
many of the issues discussed and standardise how insomnia research is planned and 
conducted thus allowing greater validity of treatment outcomes and comparisons across 
studies in future.  
 
It would seem appropriate that established researchers and research groups working in 
the field of insomnia research should lead the way by continuing to strive to implement 
the recommendations of the RWG in their research studies. This particularly applies to 
those researchers who contributed to the development of the RDC for Insomnia as if 
they do not make use of these it will be ever harder to convince others to do so. Finally, 
given the possibly premature timing of this review, and the importance of the subject 
matter to insomnia research, it is recommended that it be repeated in 3 to 5 years time to 
ascertain whether the RWG’s recommendations have finally begun to have an impact on 
research practices. 
24 
References 
 
1. American Academy of Sleep Medicine. The International Classification of Sleep 
Disorders (2nd Edition). 2005, American Academy of Sleep Medicine, Westchester, 
IL. 
2. Ohayon, M.M. Epidemiology of insomnia: what we know and what we still need to 
learn. Sleep Med Rev, 2002, 6: 97-111. 
3. Leger D, Guilleminault C, Bader G et al. Medical and socio-professional impact of 
insomnia. Sleep 2002; 25: 625-629 
4. Stoller MK. Economic effects of insomnia. Clin Ther 1994; 16: 873-897 
5. Harvey, AG. Insomnia: Symptom or diagnosis? Clin Psychol Rev, 2001, 21: 1037-
1059. 
6. Reynolds, CF., Kupfer, DJ., Buysse, DJ., et al. Subtyping DSM-III-R Primary 
Insomnia. A Literature review by the DSM IV Work Group on Sleep Disorders. Am 
J Psychiatry, 1991, 148, 432-438 
7. Buysse, DJ., Reynolds, CF., Kupfer, DJ. Et al. Effects of diagnosis on treatment 
recommendations in chronic insomnia – A report from the APA/NIMH DSM-IV 
field trial. Sleep, 1997, 20, 542-552. 
8. American Psychiatric Association. Diagnostic and Statistical Manual of Mental 
Disorders (4th edition).  American Psychiatric Association, Washington DC, 1994. 
9. Edinger, J.D., Bonnet, M.H., Booztin, R.R. et al. Derivation of research diagnostic 
criteria for insomnia: Report of an American Academy of Sleep Medicine Work 
Group. Sleep, 2004, 27: 1567-1596. 
10. Feighner JP, Robins E, Guze SB, Woodruff RA, Jr., Winokur G, Munoz R. 
Diagnsotic criteria for use in psychiatric research. Arch Gen Psychiatyr. 1972, 
26:P57-63. 
11. Spitzer R, Endicott J, Robins E. Research diagnostic criteria: rationale and 
reliability. Arch Gen Psychiatry. 1978, 35:773-82. 
12. Dixon, S., Morgan, K., Mathers, N., Thompson, J, Tomeny, M. Impact of cognitive 
behaviour therapy on health-related quality of life among adult hypnotic users with 
chronic insomnia. Beh Sleep Med, 2006, 4: 71-84. 
13. Germain, A., Moul, DE., Franzen, PL. et al. Effects of a brief behavioural treatment 
for late-life insomnia: Preliminary findings. J Clin Sleep Med, 2006, 2: 403-6. 
25 
14. Sivertsen B, Omvik, S, Pallesen, S. et al., (2006). Cognitive-behavioral therapy vs 
Zopiclone for treatment of chronic primary insomnia in older adults: A randomized 
control trial. JAMA, 2006, 295: 2851-8. 
15. Wu R. Bao J. Zhang C. Deng J. Long C. Comparison of sleep condition and sleep-
related psychological activity after cognitive-behavior and pharmacological therapy 
for chronic insomnia. Psychother Psychosom, 2006, 75:220-8. 
16. American Sleep Disorders Association International Classification of Sleep 
Disorders. Rochester, MN: American Sleep Disorders Association; 1990. 
17. Cohen, J. Statistical power analysis for the behavioural sciences. Academic Press, 
New York, 1988 (second edition). 
18. Edinger, J.D., Wohlgemuth, W.K., Radtke, R.A., Coffman, C.J. & Carney, C.E. 
Dose-response effects of cognitive-behavioral insomnia therapy: A randomized 
clinical trial. Sleep, 2007, 30: 203-12. 
19. Espie, C.A., MacMahon, K.M.A, Kelly, H.L et al. Randomized clinical effectiveness 
trial of nurse-administered small-group cognitive behaviour therapy for persistent 
insomnia in general practice. Sleep, 2007, 30: 574-584. 
20. Belleville G, Guay B, Guay C, Morin, CM.. Hypnotic taper with or without self-help 
treatment of insomnia: A  randomized clinical trial. J Consult Psychol, 2007, 75: 
325-335. 
21. Soeffing JP, Lichstein KL, Nau SD et al. Psychological treatment of insomnia in 
hypnotic-dependant older adults. Sleep Med, 2008, 9: 165-71. 
22. O’Connor K, Marchand A, Brousseau L et al. Cognitive-behavioural, 
pharmacological and psychosocial predictors of outcome during tapered 
discontinuation of benzodiazepine. Clin Psychol Psychother, 2008, 15: 1-14. 
23. Omvik S, Sivertsen B, Pallesen S, Bjorvtan B, Havik OE, Nordhus IH. Daytime 
functioning in older adults patients suffering from chronic insomnia: Treatment 
outcome in a randomized controlled trial comparing CBT with Zopiclone. Beh Res 
Ther, 2008, 46: 623-41 
24. Zavesicka L, Brunovsky M, Horacek J et al. Trazadone improves the results of 
cognitive behaviour therapy of  primary insomnia in non-depressed patients. 
Neuroendocrinology Letters, 2008, 29: 895-901. 
26 
25. Van Straten A, Cuijpers P, Smit F, Spermon M, Verbeek I. Self-help treatment for 
insomnia through television and book: A randomized trial. Pat Educat Counsel, 
2009, 74: 29-34. 
26. Ritterband LM, Thorndike FP, Gonder-Frederick L.A et al. (2009). Efficacy of an 
internet-based behavioral intervention for adults with insomnia. Arch Gen Psychiat, 
2009, 66: 692-8. 
27. Vincent N, Lewycky S. Logging on for better sleep: RCT of the effectiveness of 
online treatment for insomnia. Sleep, 2009, 32: 807-15. 
28. Morin CM, Vallieres A, Guay B et al. Cognitive behavioral therapy, singly and 
combined with medication, for persistent insomnia: A randomized controlled trial. 
JAMA, 2009, 301: 2005-2015. 
29. Riemann D, Perlis ML. The treatments of chronic insomnia: A review of 
benzodiazepine receptor agonists and psychological and behavioral therapies. Sleep 
Med Rev, 2009, 13:205-214. 
27 
Table1: Criteria for the Diagnosis of primary Insomnia 
 
DSM-IV Diagnostic Criteria for Insomnia ICSD-2 Diagnostic Criteria for Insomnia 
 
• The predominant symptom is difficulty initiating or 
maintaining sleep, or non-restorative sleep, for at least 1 
month. 
 
• The sleep disturbance (or associated daytime fatigue) causes 
clinically significant distress or impairment in social, 
occupational, or other important areas of functioning. 
 
• The sleep disturbance does not occur exclusively during the 
course of narcolepsy, breathing-related sleep disorder, 
circadian rhythm disorder or a parasomnia. 
 
• The disturbance does not occur exclusively during the course 
of another mental disorder (e.g. major depressive disorder, 
generalised anxiety disorder, a delirium). 
 
• The disturbance is not due to the direct effects of a substance 
(e.g. drug abuse, medication) or a general medical condition. 
 
 
• A complaint of difficulty initiating sleep, difficulty maintaining sleep, or 
waking up too early, or sleep that is chronically non-restorative or poor in 
quality. 
 
• The sleep difficulty occurs despite adequate opportunity for sleep. 
 
• At least one of the following forms of daytime impairment related to the 
nighttime sleep difficulty is reported: 
o Fatigue or malaise 
o Attention, concentration, or memory impairment 
o Adverse impact on school, work or social activities 
o Mood disturbance or irritability 
o Daytime sleepiness 
o Lack of energy or motivation 
o Driving errors 
o Tension, headaches or gastrointestinal symptoms 
o Excessive worries about sleep loss 
 
  
 
 
 
 
  
Psychophysiological Insomnia 
 
Disorder of somatisized tension 
and learned sleep-preventing 
association 
Idiopathic Insomnia 
 
A life-long inability to 
obtain adequate sleep. 
Paradoxical Insomnia 
 
Experiencing insomnia without 
objective evidence of any sleep 
disturbance. 
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Table 2: Study characteristics and main findings 
 
Study & 
Sample 
Size 
Sleep Diagnosis & 
Diagnostic 
Criteria Employed 
Assessment 
Procedures 
Used 
Treatment 
Type, 
Duration & 
Follow-up 
Outcome Measures Summary of Main Findings 
Wu et al. 
(2006), 15 
 
CBTi (n 
=19); Meds 
(n = 17); 
CBTi + 
Meds 
Combined 
(n = 18); 
Placebo ( = 
17) 
Chronic/Primary 
insomnia 
 
DSM-IV & 
ICSD-1 
 
Clinical Interview 
x 3 
 
 
CBTi 
(CT,SC, SR, 
SHE) 
 
8 wk; 8 mo 
 
Primary: PSG & 
sleep diary data of 
SOL, SE & TST 
 
Secondary: Pre-
sleep Arousal Scale 
(PSAS), 
Dysfunctional Beliefs 
& Attitudes About 
Sleep Scale (DBAS), 
Pittsburgh Sleep 
Quality Index (PSQI) 
 
At the end of treatment subjective SOL, SE and TST were 
better in the Medication only group than the CBTi only group. 
At 3-mth follow-up subjective and objective SOL, SE and 
TST were better in the CBTi group than in both the PCT and 
Combined group. At 8mth follow-up the CBTi group showed 
a steady sleep state whilst the medication only and 
Combined group were gradually returning to the pre-
treatment condition. The CBTi group showed significantly 
better improvement at follow-up on the PSAS, DBAS & PSQI. 
 
Soeffing et 
al. (2008), 
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CBTi (n = 
20); 
Placebo (n 
= 27) 
Hypnotic-
dependant older 
adults with Chronic 
Insomnia 
 
ICSD-2 
Clinical Interview 
 
PSG 
 
Sleep diaries 
 
Self-report 
questionnaires of 
daytime function 
 
Behavioural 
Therapy (SC, 
SHE, Rel) 
 
8 wk; No FU 
Primary: Sleep diary 
measures of SOL, 
NWAK, WASO, TST, 
SE & SQ 
 
Secondary: Self-
report daytime 
function data 
The CBTi group reported significantly better self-report 
measures of SOL, WASO and SE at post-treatment. No 
significant differences found on measures of daytime 
function. 
Zavesicka 
et al. 
(2008), 24 
 
CBTi (n = 
10); CBT + 
Meds (n = 
10) 
Chronic Insomnia 
 
DSM-IV 
Clinical Interview 
 
PSG 
 
Sleep diaries 
 
Self-report 
questionnaires 
CBTi (SR; 
SC, SHE CT; 
and Rel) 
 
8wk; No FU 
 
Primary: PSG data of 
TST, SOL, WASO & 
SE, Insomnia 
Severity Index (ISI), 
Epworth Sleepiness 
Scale (ESS) 
 
Both groups reported significant post-treatment 
improvements in PSG measured SOL, SE and TST and self-
reported insomnia severity and daytime sleepiness. No 
significant between group differences were found. 
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 Secondary: PSG 
measured sleep 
architecture 
Van Straten 
et al. 
(2009), 25 
 
CBTi (n = 
126); WL 
Control (n = 
121) 
Subjects with sleep 
problems 
 
Age 18+, Lying 
awake at night for 
>30 mins x 3 per 
wk for >= 1mth 
Brief telephone 
interview to 
establish 
inclusion criteria 
 
 
 
Self-help 
CBTi (Sleep 
Education, 
SHE, SR, 
SC, Rel and 
CT) 
 
6wk; No FU 
Primary: Sleep diary 
data of TST, SOL, 
SE, SQ  
 
Secondary: Use of 
sleep meds, Sleep 
Evaluation Form 
(SEF), DBAS 
Both groups improved significantly with respect to TST, SOL 
& SE but there were no significant between group 
differences. The treatment group reported significantly better 
improvements on Sleep Quality, SEF and DBAS. 
 
Ritterband 
et al. 
(2009), 26 
 
CBTi (n = 
22); WL 
Control (n = 
23). 
Primary insomnia 
 
DSM-IV-TR 
Clinical Interview 
 
Sleep diaries 
 
 
CBTi via 
Internet (SR, 
SC, SHE, CT 
& Relapse 
prevention) 
 
9wk; 6mth 
 
Primary: ISI, Sleep 
diary data of WASO 
& SOL 
 
Secondary: SE, TST, 
NWAK, Time in bed, 
Feeling restored & 
Soundness of Sleep. 
The CBTi group showed statistically and clinically significant 
improvement post-treatment on ISI whereas the control 
group did not show change. The gains were maintained at 
6mth follow-up. The CBTi group also showed significant 
improvements in WASO and SE at post-treatment. 
 
Vincent & 
Lewycky 
(2009), 27 
 
CBTi (n = 
59); WL 
Control (n = 
59) 
Chronic Insomnia 
 
AASM RDC 
Clinical Interview 
 
Sleep diaries 
 
 
Online CBTi 
(SHE, SC, 
SR, 
Relaxation, 
CT & Sleep 
meds 
tapering. 
 
5wk; 4wk 
 
Primary: Sleep diary 
data of SQ, TST, 
SOL, SE, NOW & 
WASO; ISI, Multi-
Dimensional Fatigue 
Inventory (MFI) 
 
Secondary: DBAS, 
Clinical Global 
Improvement Scale 
(CGI) 
The treatment group showed significant improvements in SQ 
and ISI at post-treatment which were maintained at 4wk 
follow-up. They also showed significant improvement in 
General Fatigue at post-treatment. Significant changes on 
PSAS and DBAS were also reported. 
 
Key: 
 
DSM-IV: Diagnostic and Statistical Manual of Mental Disorders 4th edition; DSM-IV: Diagnostic and Statistical Manual of Mental Disorders 4th Edition - Text Revision; ICSD-1: 
International Classification of Sleep Disorders - 1st Edition; ICSD-2: International Classification of Sleep Disorders - 2nd Edition; PSG: Polysomnography; CBTi: Cognitive 
Behaviour Therapy for Insomnia; CT: Cognitive Therapy; SC: Stimulus control; SR: Sleep restriction; SHE: Sleep hygiene education; Rel: Relaxation; SOL: Sleep onset latency; 
NWAK: Number of wakenings; WASO: Wake time after sleep onset; TST: Total sleep time; SE: Sleep efficiency; SQ: Sleep Quality. 
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Table 3: Assessment procedure and information reporting ratings for each study 
 
Study Item 1  Item 2 Item 3 Item 4 Item 5 
Assessment 
Procedure 
Score 
Item 6 Item 7 Item 8 Item 9 Item 10 Item 11 
Information 
Reporting 
Score 
Total 
Score 
Wu et al. 
(2006) 2 2 0 0 0 4/12 2 2 2 0 0 0 6/12 10/24 
Soeffing et 
al. (2008) 4 0 0 2 2 8/12 2 2 2 0 0 0 6/12 14/24 
Zavesicka 
et al. 
(2008) 
2 0 0 2 2 6/12 0 2 2 2 0 0 6/12 10/24 
van 
Straten et 
al. (2009) 
0 0 0 0 0 0/12 2 2 2 2 0 2 10/12 10/24 
Ritterband 
et al. 
(2009) 
4 0 0 0 2 6/12 2 2 2 2 2 2 12/12 18/24 
Vincent & 
Lewycky 
(2009) 
4 0 0 0 2 6/12 0 2 2 0 0 2 6/12 12/24 
 
Key: 
 
Item 1. Was a clinical interview used? Yes (2 points) No (0 points)  Structured or Semi-structured (2pts) Unstructured or Don’t Know (0pts) 
Item 2. Were independent interviewers used?   Yes (2 points)  No (0 points) 
Item 3. Was inter-rater reliability checked?   Yes (2 points)  No (0 points) 
Item 4. Were Polysomnography data collected?   Yes (2 points)  No (0 points) 
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Item 5. Were Sleep Diary/Log data collected?   Yes (2 points)  No (0 points) 
Item 6. Recruitment methods employed  Yes (2 points)  No (0 points) 
Item 7. Types of individuals enrolled i.e. clinical or volunteer participants?  Yes (2 points)  No (0 points) 
Item 8. Means, std deviations and ranges of sleep measures e.g. TST, SOL, WASO, SE? Yes (2 points)  Partially (1 point)  No (0 points) 
Item 9. Means, std deviations and distribution of insomnia duration? Yes (2 points)  Partially (1 point)  No (0 points) 
Item 10. Means and distribution of insomnia frequency?  Yes (2 points)  Partially (1 point)  No (0 points) 
Item 11. Means and std deviations of discrepancies between subjective estimates and objective measures of sleep measures? Yes (2 points) Partially (1 point)  No (0 points)
   Not Applicable (2 points) 
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Table 4: Standardised effect sizes of Cognitive Behaviour Therapy for Insomnia on sleep parameters at post-treatment 
 
 
*As measured by PSG 
 
Note: Effect sizes for the Zavesicka et al.(2008) study relate to within group and not between group differences as the comparison group in the study received 
CBTi + medication 
Outcome Variable Wu et al. (2006) 
Soeffing et al. 
(2008) 
Zavesicka et al. 
(2008) 
van Straten et al. 
(2009) 
Ritterband et al. 
(2009) 
Vincent & 
Lewycky (2009) 
Sleep Onset 
Latency 1.31* 0.55 0.92* -0.10 0.99 0.50 
Wake After Sleep 
Onset - 0.53 0.59* -  0.13 
Number of 
Awakenings - - - - 0.71 0.68 
Total Sleep Time 1.01* - 0.57* -0.15 0.41 0.24 
Sleep Efficiency 0.49* 0.89 0.91* 0.00 1.23 0.23 
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Figure 1: Summary of literature search yield and study inclusion/exclusion process 
Potentially relevant papers 
identified by electronic database 
search n = 335  
Total full text obtained and screened 
n = 15 
Studies excluded on basis of 
title and abstract n = 320 
 
Studies excluded as data was collected prior to 
the publication of the AASM Research 
Diagnostic Criteria in 2004 n = 9 
 
Dixon et al. (2006) 
Germain et al. (2006) 
Sivertsen et al. (2006) 
Edinger et al. (2007) 
Espie et al. (2007) 
Belleville et al. (2007) 
O’Connor et al. (2008) 
Omvik et al. (2008) 
Morin et al. (2009) 
Suitable studies n = 6 
Potentially relevant papers 
identified by grey literature search 
and screened n = 0 
Total studies included in 
systematic review n = 6 
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CHAPTER TWO: MAJOR RESEARCH PROJECT 
 
Psychophysiological Insomnia and Idiopathic Insomnia: The role of self-
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Abstract 
 
 
Further research into identifying the mechanisms that underlie the development and 
maintenance of insomnia and its different subtypes is required. Neurobiological 
motivational systems are thought to mediate our experiences of negative and positive 
affect and are implicated in the etiology of psychiatric disorders, but their role in 
insomnia is unknown. The present study aimed to compare self-reported sensitivity to 
these systems across Psychophysiological Insomnia (PI) and Idiopathic Insomnia (IdI). 
Sixty one adults with PI (n = 20) and IdI (n = 20), and Good Sleepers (n = 21), 
completed measures of sleep characteristics, Behavioural Inhibition Sensitivity (BIS), 
Behavioural Activation Sensitivity (BAS), Sleep Effort, Depression and Anxiety. As 
predicted the PI group reported significantly greater BIS sensitivity compared with the 
IdI and GS groups. However, no significant differences were found between groups on 
BAS sensitivity. Post-hoc analysis revealed significant differences between the 
insomnia groups on sleep effort when age was included as a covariate. Depression and 
anxiety did not moderate the relationships between the other outcome variables. The 
findings support the notion that PI is associated with a specific tendency toward threat 
sensitivity, a tendency absent in IdI. This is consistent with contemporary thinking on 
PI that this group exhibits greater vulnerability to stress-related sleep disturbance, 
whereas IdI is a more stable insomnia subtype that may be less reactive to 
circumstances. Accordingly, this suggests that different psychological treatment 
approaches are indicated for these subtypes with PI requiring re-conditioning forms of 
CBT and IdI requiring a more acceptance based approach. 
 
Keywords: Insomnia, Psychophysiologic Insomnia, Idiopathic insomnia, Behavioural 
Inhibition System, Behavioural Activation System, Sleep Effort 
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INTRODUCTION 
 
Insomnia is the most prevalent disorder of sleep and is thought to affect from 6-38% of 
adults (Ohayon, 2002). However, it is a poorly understood condition and is frequently 
viewed by clinicians as merely a symptom of other so-called ‘primary’ health 
disorders rather than a clinical disorder in its own right. Consequently, insomnia 
symptoms can often go untreated in favour of targeting the ‘primary’ disorder (Harvey, 
2001). In addition, despite differences in the known characteristics and apparent 
treatability of different insomnia subtypes, they are usually managed in the same way. 
The International Classification of Sleep Disorders, 2nd Edition (ICSD-2), (American 
Academy of Sleep Medicine, 2005) lists diagnostic criteria for 3 primary insomnia 
subtypes; Psychophysiological Insomnia, Idiopathic Insomnia and Paradoxical 
Insomnia. The present study aimed to investigate the first and second of these 
subtypes. 
 
Research into the psychological mechanisms that may be implicated in the 
development and maintenance of insomnia has resulted in a number of explanatory 
models being put forward (Perlis et al., 2005). Harvey (2002) proposed a cognitive 
model of primary insomnia which focussed on processes that might maintain the 
disorder rather than be the cause of it. The model suggests that excessive worry and 
anxiety about sleep and the consequences of not getting enough sleep leads to 
cognitive arousal, emotional distress and selective attention toward both internal and 
external sleep-related threat stimuli. This in turn leads to the development of 
dysfunctional perceptions and beliefs about sleep and engagement in 
counterproductive safety behaviours that serve to impede sleep and thus perpetuate the 
sleep difficulty. 
 
The neurocognitive model of insomnia developed by Perlis et al., (1997) is based on a 
behavioural concept of insomnia and suggests that chronic insomnia is primarily a 
central nervous system disorder relating to behavioural factors and classical 
conditioning. Whilst this model acknowledges that cognitive processes such as 
rumination and worry may prolong wakefulness, it does not see them as being 
responsible for the individual’s inability to initiate or maintain sleep. Instead the 
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neurocognitive model posits that conditioned somatic, cognitive and cortical arousal 
underlie chronic insomnia and that cortical arousal interferes with sleep via heightened 
sensory and information processing and increased long-term memory (Perlis et al., 
2005). Similar to Harvey’s (2002) cognitive model the neurocognitive model 
implicates the possible role of attention bias toward salient sleep-related stimuli and 
threat cues in the development and maintenance of insomnia.  
 
The cognitive and neurocognitive models of insomnia are two of several that frame 
insomnia as a disorder of hyperarousal of cognitive and/or physiological systems 
within the individual (Perlis et al, 2005). Conversely, Espie’s (2002) Psychobiological 
Inhibition Model proposes that it is disruption to the physiological, cognitive, 
affective, and behavioural processes which normally inhibit wakefulness and thus 
allow sleep to come which underlies the development of insomnia. Within this concept 
the failure to inhibit wakefulness through de-arousal is attributed to an inability to 
sleep drawing the individual to pay attention to a usually automatic process and trying 
to exert control over it. This process has the unintended effect of serving only to 
sustain wakefulness and for some over time leading to the cognitive and behavioural 
patterns that characterise and maintain insomnia.  
 
More recently the psychobiological inhibition model of insomnia was extended by 
Espie and colleagues to form their Attention-Intention-Effort (A-I-E) Pathway Model 
of Psychophysiologic Insomnia (PI) (Espie et al., 2006). Like the psychobiological 
inhibition model the A-I-E model posits that the sleep-wake process is primarily self-
regulatory and is vulnerable to disruption by focussed attention on sleep-related cues 
and stimuli and by effortful attempts to control its operation. Essentially the model 
proposes that the sleep-wake process can be disrupted by selectively attending to 
sleep, explicitly intending to sleep, and by making effortful attempts to initiate sleep. 
Prolonged disruption of this normally self-regulatory process over time then leads to 
the development and maintenance of PI. The concept at the heart of this model mirrors 
that proposed for other psychiatric disorders, such as anxiety and depression, in that an 
attentional bias toward salient cues and stimuli is said to be involved in the etiology of 
the disorder (Dalgleish & Watts, 1990). In the case of those with PI, selective attention 
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toward sleep related cues is thought to be associated with the experience of ‘craving’ 
or ‘incentive’ for sleep and heightened awareness of potential ‘threat’ to the sleep-
wake process (Espie et al., 2006). 
 
Although there are some clear differences between the approaches of each of the above 
models of insomnia they all implicate the role of cognitive, behavioural and 
physiological processes in either the development and/or maintenance of insomnia. 
The inclusion of these factors within the models is supported by the results of research 
investigating them. For example, evidence supporting the cognitive model of insomnia 
can be found in studies where the pre-sleep thoughts of insomnia patients have been 
investigated (Harvey, 2000; Nelson & Harvey, 2003; Wicklow & Espie, 2000; and 
Waine et al., 2009). These studies have shown that insomnia patients often experience 
intrusive pre-sleep thoughts about a wide range of internal and external sleep-related 
stimuli and can also develop dysfunctional beliefs and misperceptions about their sleep 
and their ability to sleep. With regards to the neurocognitive model of insomnia, 
studies measuring electrical activity in the brain have found increased activity in 
primary insomnia patients in the sleep-onset period and during non-rem sleep thus 
supporting the suggestion that cortical arousal plays a role in insomnia (Bastien & 
Bonnet, 2001, Perlis et al., 2001). Similarly a recent study by Bastien et al., (2008) 
sought to explore both the neurocognitive and psychobiological inhibition models 
utilising measures of electrical activity in the brain to compare psychophysiological 
insomnia individuals with good sleepers. They found evidence of both cortical arousal 
and difficulties with disengaging from wake processes in the insomnia subjects thus 
providing empirical support for both theoretical viewpoints. 
 
A feature of the insomnia models outlined that is of particular interest to the current 
study is that they all either explicitly include or allow for the inclusion of attention bias 
toward sleep-related stimuli as a mechanism that may play a role in insomnia. This is 
an area that has received much research attention of late and there is now a growing 
evidence base from studies, using both subjective and objective measures of attention, 
to support the position that patients with insomnia show attention biases toward sleep-
related threat cues (Neitzert Semler & Harvey, 2004a, 2004b; Marchetti et al., 2006; 
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MacMahon et al., 2006; Woods et al., 2009). For example, in their recent study Woods 
et al. (2009) used a cognitive probe task to investigate the role of the clock as a focus 
of selective attention in insomnia. They utilised a modified Posner paradigm to 
compare reaction times between subjects with primary insomnia and good sleepers and 
found that the insomnia group demonstrated delayed disengagement to the clock. This 
finding can be seen as further support for those insomnia models which incorporate 
selective attention towards salient stimuli as being important to the maintenance of 
primary insomnia. 
 
Insomnia subtypes 
 
Psychophysiological Insomnia 
 
Psychophysiological Insomnia (PI) is the most common form of persistent primary 
insomnia and is found in 1-2% of the general population, and 12-15% of those 
presenting for treatment (Espie et al., 2006). It develops in adulthood, can often be 
linked to identifiable precipitating events and/or stressors, and comprises both 
psychological and physiological features such as conditioned arousal, sleep-
incompatible behaviour, sleep preoccupation, and excessive focus on and anxiety 
about sleep (Harvey, 2001) Clinical treatment research has demonstrated that PI can be 
treated effectively using psychological interventions (e.g. Cognitive Behaviour 
Therapy for Insomnia) (Morin et al., 2006 and Riemann & Perlis, 2009) thus 
suggesting that both behavioural and cognitive factors play a part in the aetiology of 
PI. 
 
Idiopathic Insomnia 
To date few studies have investigated the nature of Idiopathic Insomnia (IdI), also 
known as Childhood Onset Insomnia, and it has proved to be a conceptually difficult 
disorder to define and research (Greene, 2008). The ICSD-2 describes IdI as a 
longstanding insomnia complaint with a chronic and persistent course, few periods of 
sustained remission, and onset during infancy or early childhood. IdI is thought to 
affects around 1% of adults and is seen in less than 10% of those presenting with an 
insomnia complaint (Ohayon, 2002; American Academy of Sleep Medicine, 2005). 
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Unlike PI, there is usually an absence of identifiable precipitating and maintaining 
factors in relation to the sleep difficulties of those with IdI. 
 
IdI patients typically show only minor psychological abnormalities although there is 
limited evidence that some may adopt denial and repression as coping strategies and of 
an association with neurodevelopmental disorders such as ADHD and Dyslexia (Hauri 
& Olmstead, 1980; Hauri, 1983). Hauri and Olmstead’s (1980) findings also revealed 
differences in sleep architecture between participants with PI and IdI which indicated 
that people IdI sleep differently to those with PI. In addition, Edinger et al., (1988) 
found that participants who reported childhood onset insomnia displayed higher levels 
of arousability and were largely unresponsive to behavioural treatment methods. These 
findings lend weight to Hauri & Olmstead’s (1980) suggestion that IdI may have less 
of a psychological and more of a neurophysiologcial aetiology than PI. Further to this, 
in the only recent and diagnostically robust study of adults with IdI, Barrie and Espie 
(2009) investigated how participants with IdI and PI conceptualised and accepted their 
sleep difficulties. The IdI group perceived their insomnia to be more permanent and 
rated an acceptance-based treatment approach as more acceptable than the PI group. 
Interestingly though, in view of Edinger et al’s (1998) findings about treatment 
response in IdI, both groups rated behavioural therapy as more acceptable than either a 
pharmacological or acceptance-based approach. 
 
Self-regulatory Behaviour Systems 
 
Motivational theorists argue that a continual process of moving toward, and away 
from, mental goal representations underlies human behaviour (Carver & Scheier, 
1998). Put simply, such a model proposes that human behaviour is motivated by the 
pursuit of desirable goals and pleasure, and the avoidance of negative outcomes and 
displeasure. Gray (1982, 1987, 1994) endorses this view and suggests that two main 
general motivational systems regulate behaviour and affect; a Behavioural Inhibition 
System (BIS) and a Behavioural Activation System (BAS). 
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The BIS is said to be involved in the experience of negative affect, and the anticipation 
and avoidance of threat and negative outcomes. Indeed, Gray argued that this 
mechanism underlies the experience of anxiety (Gray, 1987, 1994; Gray & 
McNaughton, 2000). Figure 1 shows a diagrammatic representation of the BIS as Gray 
(1982) conceived it. The BAS on the other hand is thought to control appetitive 
motivation and to be sensitive to signals of reward and is therefore more implicated in 
the experience of positive affect, and the facilitation of behaviour that may lead to 
positive outcomes. 
 
(INSERT FIGURE 1 HERE) 
 
Carver and White (1994) developed the Behavioural Inhibition/Behavioural Activation 
Scale (BIS/BAS Scale) to assess dispositional sensitivities to Gray’s two motivational 
systems. Research using the BIS/BAS Scale has shown that when threat occurs 
individuals high in BIS sensitivity tend to experience more negative affect and be more 
anxious, distressed, and avoidant than persons lower in BIS sensitivity (Campbell-Sills 
et al., 2004; Bijttebier et al., 2009). Conversely, those high in BAS sensitivity 
experience greater positive affect and engage in more approach behaviour than those 
lower in BAS sensitivity. Low levels of BAS sensitivity have also been associated 
with negative affect suggesting that high levels of BAS sensitivity may be protective 
(Carver & White, 1994;.Gable et al., 2000, Kasch et al., 2002, O’Connor & Forgan, 
2007 and Bijttebier et al., 2009). 
 
Neurobiological Motivational Systems and Primary Insomnia 
 
Attentional biases to threat and their relationship with behaviour and experiences of 
affect are implicated in models of insomnia, particularly the A.I.E. pathway model of 
PI (Espie et al., 2006), and also in Gray’s model of neurobiological motivational 
systems (Gray, 1982, 1987 & 1994). In addition, variation in BIS/BAS sensitivity has 
previously been associated with the presence of psychopathology. Therefore, it would 
seem reasonable to hypothesize that BIS/BAS sensitivity may play a role in the 
development and maintenance of PI and that differing levels of BIS/BAS sensitivity 
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might be found between those with PI and normal sleepers. Figure 2 shows how many 
of the features of poor sleep and insomnia might map onto Gray’s (1982) BIS model. 
Additionally, given the previously found differences in the characteristics of the PI and 
IdI insomnia subtypes, it would also seem appropriate to raise the question of whether 
they may also show differences in BIS/BAS sensitivity.  
 
(INSERT FIGURE 2 HERE) 
 
The present study aimed to address these areas of enquiry and extend our knowledge 
of the PI and IdI insomnia subtypes by measuring self-reported BIS/BAS sensitivity 
amongst adults who meet criteria for PI and IdI, and normal sleep. Given that sleep 
effort is also said to play a key part in the aetiology of PI, but its role in IdI is 
unknown, a measure of sleep effort was also employed. The Glasgow Sleep Effort 
Scale (GSES; Broomfield & Espie, 2005) allows sleep effort to be investigated as an 
overall construct and at the level of the core components which comprise Broomfield 
and Espie’s proposed model of sleep effort such as anxiety about sleep, avoidance of 
sleep, control over sleep and dysfunctional beliefs about sleep performance. Measures 
of depression and anxiety were also administered in order to investigate the potential 
relationships between insomnia, BIS/BAS sensitivity and psychopathology. 
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AIMS and HYPOTHESES 
 
Aims 
The present study aimed to address the following research questions: 
 
Primary questions: 
 
1. Do those with PI and IdI report differing levels of BIS/BAS sensitivity 
compared to good sleepers? 
2. Do those with PI report differing levels of BIS/BAS sensitivity compared to 
those with IdI? 
 
Secondary questions: 
3. Do those with PI report differing levels of Sleep Effort compared to those with 
IdI? 
4. Do Anxiety and Depression moderate the relationships between PI, IdI, 
BIS/BAS sensitivity and Sleep Effort? 
 
Hypotheses 
 
In view of the exploratory nature of the study, the following tentative hypotheses were 
posited: 
 
1. Participants with PI will report greater levels of BIS sensitivity than normal 
sleepers and those with IdI. 
2. Participants with PI will report lower levels of BAS sensitivity than normal 
sleepers. 
3. Participants with IdI will report greater levels of BAS sensitivity than those 
with PI. 
4. Participants with PI will report greater levels of overall Sleep Effort than those 
with IdI and will differ in terms of their responses to individual GSES items 
relating to different core components of the sleep effort construct. 
5. Participants with PI who report greater levels of psychopathology will also 
report greater levels of BIS sensitivity. 
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Methods 
 
Participants 
The study participants were aged 18 to 65 years of age and met criteria for inclusion in 
either a Psychophysiological Insomnia (PI) group, Idiopathic Insomnia (IdI) group, or 
Good Sleeper (GS) group. Participants in the PI and IdI groups were required to meet 
the diagnostic criteria for these insomnia subtypes, as outlined in the ICSD-2 
diagnostic classification system (AASM, 2005) (See Appendix B.3) and sleep 
disturbance criteria as indicated by scores of >5 on the Pittsburgh Sleep Quality Index 
(PSQI) and > 8 (Moderate Insomnia) on the Insomnia Severity Index (ISI). The GS 
group was required to meet research diagnostic criteria for normal sleepers (Appendix 
B.3) as recommended by the American Academy of Sleep Medicine Work Group 
(Edinger et al., 2004). To ensure a clear distinction between the insomnia groups, the 
PI group was required to have developed insomnia after the age of seventeen and the 
IdI group by the age of twelve. 
 
Exclusion criteria were: presence of another sleep disorder such as narcolepsy, sleep 
apnoea, restless legs syndrome, circadian sleep disorders or parasomnias; presence of 
severe psychopathological disorder; experiencing a somatic disorder directly related to 
the onset and course of insomnia; evidence of substance abuse; and taking medications 
known to influence sleep. Participants with stable medical or psychiatric disorders 
were included in the study provided that these conditions were not thought to be the 
primary cause of their insomnia difficulty. 
 
A total of 98 potential participants expressed an interest in taking part in the study. Of 
these 20 were not invited to participate in the study after completing an initial 
telephone screening interview as they did not meet the study inclusion criteria. A 
further eight interested participants were excluded following a semi-structured clinical 
interview. Four of these had symptoms which indicated the presence of another sleep 
disorder (e.g. Restless Legs Syndrome, Paradoxical Insomnia) and four reported 
having a current diagnosis of a psychiatric disorder (e.g. Attention Deficit 
Hyperactivity Disorder, Borderline Personality Disorder) which may have been the 
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primary cause of their insomnia difficulty. Six participants were also excluded after 
returning their completed questionnaires as their scores on the measures of anxiety (3 
participants) and depression (3 participants) were indicative of severe levels of these 
difficulties and as such may have been underlying their sleep problems. Three other 
participants who took part in the semi-structured clinical interview but did not return 
their completed questionnaires to the researcher were also excluded. Of the 98 
potential participants who showed an interest in the study 61 were included in the final 
sample.  
 
Demographic information was collected in relation to all participants’ age and gender. 
Address and postal code data were also collected for the insomnia participants whereas 
this data was only collected from good sleepers who wished to be sent details of the 
outcome of the study once it was completed. Only five of the GS group provided their 
address details. 
 
Procedure 
 
Participant recruitment 
Participants were recruited using established and ongoing University of Glasgow Sleep 
Centre (UGSC) recruitment methods, including emails to University of Glasgow 
students and staff, articles on university web pages, placement of notices in NHS staff 
newsletters; posters in NHS facilities including GP surgeries, newspaper 
advertisements etc, and contacting individuals who previously participated in sleep 
research and had given permission to be contacted for other studies. Publicity for the 
study was gained via news articles on a Scottish national television news programme 
and in a national newspaper. The GS group were recruited via the above methods and 
also from within the staff group at the researchers place of work and social 
connections. 
 
Research Procedure 
Volunteers were invited to contact the researcher or UGSC by e-mail or telephone. 
Those with a sleep problem were then screened via a brief telephone interview 
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(Appendix B.4) to assess their possible suitability for participation in relation to the 
study inclusion and exclusion criteria. A participant information sheet (Appendix B.5) 
and consent form (Appendix B.6) was then sent to potential participants and they were 
invited to participate. Upon receiving the completed consent forms the researcher then 
despatched the self-report measures and a 7-day sleep diary (Appendix B.7) and 
arranged to conduct a semi-structured clinical interview with the participants 
(Appendix B.8) either via telephone or in person at the UGSC. Allocation of 
participants to the insomnia groups took place once participants had returned the self-
report measures and had completed the clinical interview. Volunteers for the GS group 
were sent a participant information sheet and were asked to complete and return a 
consent form and brief questionnaire relating to their sleep (Appendix B.9). 
 
Study design 
The study consisted of a quasi-experimental between-groups design with three groups: 
Adults with either PI or IdI and Good Sleepers (GS). Efforts were made to balance the 
groups in terms of gender and age. The primary dependent variables in relation to the 
stated hypotheses were participants’ scores on the BIS/BAS Scales and Glasgow Sleep 
Effort Scale (GSES), with scores on the Beck Depression Inventory II (BDI II) and 
Beck Anxiety Inventory (BAI) being the secondary dependent variables. Group was 
the main independent variable. 
 
Sample size/Power calculation 
To our knowledge no previous studies have investigated the relationship between 
insomnia and BIS/BAS sensitivity. Therefore it was not possible to calculate the 
optimal sample size required for the proposed study by referring to previous findings 
in this area. In addition, previous research which has investigated psychological 
variables in persons with IdI is extremely limited. However, Hauri & Olmstead (1980) 
did compare adults with childhood and adult onset insomnia using sample sizes of 
n=20 and n=39 respectively, and found significant differences between the groups on 
sleep related characteristics. 
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With regards to the BIS/BAS scales, much of the previous research utilizing these has 
looked at within group differences. However, Kasch et al., (2002) examined BIS/BAS 
sensitivity in 62 depressed participants and 27 non-depressed controls. They found that 
the depressed participants reported significantly lower levels of BAS and higher levels 
of BIS. Effect sizes (calculated from reported means & standard deviations) were as 
follows: BIS d = 1.12, BAS Drive d = .99, BAS Reward Responsiveness d = .94 and 
BAS Fun Seeking d = .86. In accordance with Cohen’s (1998) effect size conventions 
such figures correspond to large effects. Given that the present study’s primary 
hypotheses related to between group differences it was felt that a medium to large 
effect size of around 0.7 would seem reasonable for the proposed investigation. A 
series of power calculations revealed that an estimated 24 participants per group would 
be required to detect significant differences between the groups. Implementing robust 
diagnostic criteria for group allocation and demographically matched groups would 
also enhance the power of the study to detect any differences. 
 
Assessment measures 
In order to ascertain that participants met the study inclusion criteria and were 
allocated to the correct group the following measures were administered: 
 
1. Pittsburgh Sleep Quality Index (PSQI; Buysse et al., 1989) The PSQI provides a 
reliable, valid and standardized measure of sleep quality; to discriminate between 
good and poor sleepers. It consists of 19 self-rated items and 5 items rated by the 
bedpartner or roommate which are used for clinical information only. The 19 self-
rated items are grouped into seven component scores, each weighted equally on a 
0-3 scale. These component scores are summed to yield a global PSQI score with a 
range of 0-21. A PSQI global score >5 indicates that a subject is having severe 
difficulty in at least two areas, or moderate difficulty in more than three areas of 
sleep quality. Recent, independent study has validated this cut off and confirmed 
reliability (Cronbach’s alpha = 0.85, test–retest r = 0.84; Backhaus et al., 2002). 
Cronbach’s alpha for the current sample was adequate a = .67. 
 
48 
2. Insomnia Severity Index (ISI; Bastien et al., 2001) The ISI is a 7 item (Total score 
range 0-28) self-report measure, which asks the rater to state how severe their 
insomnia is, how much they feel it, the impact it has on their life and how 
distressed they are by it. A score of 8 or more is suggestive of insomnia. The ISI 
has been reported to be a reliable and valid instrument with an alpha co-efficient of 
internal consistency of 0.74 (Bastien et al., 2001). For the current sample 
Cronbach’s alpha was 0.77. 
 
3. Participants were also asked to complete a sleep diary for seven days. Data from 
the diary were reviewed to ensure participants met study inclusion criteria for 
insomnia and did not have a sleep complaint that might be better characterised by 
other forms of sleep disorder. 
 
In order to test the stated hypotheses of the present study the following measures were 
administered: 
 
1. BIS/BAS sensitivity was assessed using the Behavioural Inhibition Scale (BIS) and 
Behavioural Activation Scales (BAS) (Carver & White, 1994) which comprise 24 
items in total (Items 1, 6, 11, & 17 are fillers which are not scored) with four 
subscales. Respondents rate each item on a 4-point scale ranging from 1 (very true 
for me) to 4 (very false for me). One scale reflects BIS sensitivity (7 items; score 
range 7 to 28), and three reflect aspects of BAS sensitivity: BAS Drive (4 items; 
score range 4 to 16); BAS Fun Seeking (4 items; score range 4 to 16); and BAS 
Reward Responsiveness (5 items; score range 5 to 20). The three aspects of BAS 
sensitivity derive from diverse theoretical statements about how BAS functioning 
should be reflected experientially. The three BAS-related scales were designed to 
reflect these somewhat distinct functions (Carver et al., 2000). Higher scores on 
each scale indicate greater levels of BIS/BAS sensitivity. The internal 
consistencies for the BIS/BAS Scales for the present sample were adequate: 
Cronbach’s alphas = .77, .76, .78, and .70, for the BIS scale, BAS Drive, BAS Fun 
Seeking, and BAS Reward Responsiveness, respectively. Whilst it is feasible to 
merge the BAS scales to create an overall total BAS score for the purposes of 
analysis, this has been cautioned against by the author’s of studies where factor 
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analysis of the BIS/BAS scales has supported a four factor structure and highlight 
the importance of treating the BAS subscales as independent constructs (Campbell-
Sills et al., 2004 and Ross et al., 2002). Accordingly the current study has adopted 
this approach and analysed the BAS scales separately and not as one overall scale. 
 
2. Glasgow Sleep Effort Scale (GSES; Broomfield & Espie, 2005) The GSES is 
designed to assess effortful preoccupation with sleep and is comprised of 7 items. 
Each item is rated on a 3-point scale from 0 to 2 with a totals scale score range 
from 0 to 14. Sleep Effort is an important construct within the ICSD-2 definition of 
PI; and is the ‘end state’ of the proposed Attention-Intention-Effort pathway. The 
GSES has a single factor structure but as each item relates to a different core 
component of Broomfield & Espie’s overall model of sleep effort this also allows 
for comparisons at the individual item level. The internal consistency for the 
current sample was (α =.80). The 7 items of the GSES are presented in Table 4. 
 
3. Beck Depression Inventory II (BDI-II; Beck et al., 1996) The BDI-II is a 21-item 
self-report form covering symptoms of depression experienced by respondents 
during the previous two weeks. Each item is rated on a 4-point scale from 0 to 3 
with a total scale score range of 0 to 63. A cut-off score of 20 or above suggest 
moderate to severe depression. The BDI-II demonstrates high internal consistency, 
with Cronbach’s alpha being .86 for the present sample. The BDI-II includes two 
items which relate to respondent’s experiences of changes in their sleeping pattern 
and levels of tiredness or fatigue over the previous two weeks. These are rated on 
Likert scales which indicate whether or not there has been any change in these 
symptom areas. It would seem reasonable to hypothesize that some respondents 
who meet the criteria for an insomnia disorder may not indicate on these items that 
there has been any change over the previous two weeks as their sleep difficulties 
are chronic and long-term. However, they would in fact likely be experiencing 
ongoing difficulties with both their sleep pattern and level of tiredness or fatigue 
but underreporting these within the context of completing the BDI-II. Accordingly, 
it was felt that this could represent a confounding variable within the present study 
so respondent’s scores on these two items were not included in the data analyses. 
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4. Beck Anxiety Inventory (BAI; Beck et al., 1988) The BAI is a 21 item 
questionnaire that measures the severity of anxiety in adults.  Each item is rated on 
a 4-point scale from 0 to 3 with a total scale score range of 0 to 63. It is widely 
accepted that a score of ’30’ or above serves as a measure of severe anxiety.  The 
psychometric properties of BAI have been widely studied, resulting in high 
internal consistency α = 0.92 and excellent test-retest reliability r (81) = 0.75 (Beck 
et al.; 1988). Cronbach’s alpha for the current sample was .91. 
 
Data Analysis 
Data analyses were conducted using the Statistics Package for the Social Sciences for 
Windows (SPSS for Windows version 15) software package. The data were checked 
using graphical and numerical methods with reference to skewness and kurtosis values 
to ensure that they were normally distributed. Due to the exploratory nature of the 
study and associated potential for Type II error, an alpha level of .05 (two-tailed) was 
initially employed in the analyses. Where appropriate this was later adjusted to correct 
for multiple comparisons using the Bonferroni adjustment procedure. 
 
Descriptive statistics were calculated to describe the sample in terms of demographic, 
clinical and sleep related characteristics. One-way ANOVA’s, Independent Samples t-
tests, Chi squared tests and Correlation analyses were initially employed to compare 
the groups. Where appropriate ANCOVA’s and MANCOVA’s were utilized to further 
investigate the effect of potential covariates on any between-group differences. 
 
Ethics Approval 
Ethical approval was obtained from NHS Greater Glasgow and Clyde Primary Care 
Ethics Committee. Management approval for the protocol was granted by NHS 
Greater Glasgow and Clyde Research & Development Directorate (Appendix B.10). 
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RESULTS 
 
Sample demographics and sleep characteristics 
A total of 61 eligible participants completed the study [Mean age = 44yrs; s.d. = 
12.9yrs] 44 (72.1%) of whom were female. On the basis of the diagnostic and 
inclusion criteria employed 21 participants were categorised as Good Sleepers (GS), 
20 as having Psychophysiological Insomnia (PI) and a further 20 as having Idiopathic 
Insomnia (IdI). Demographic and sleep characteristics are presented in Table 1. The 
address and postal code data collected from the insomnia participants indicated that 
78% lived in Scotland with the remaining 22% living in England. An indicator of 
socioeconomic status (Social Deprivation Index) was gathered for those participants 
who lived in Scotland. The groups did not differ significantly on this measure [t (31) = 
-1.89, p = .068]. 
 
(INSERT TABLE 1 HERE) 
 
Table 1 shows that whilst there were no gender differences between groups (χ2 = .132, 
p = .936) a one-way ANOVA revealed that the mean age of the GS group was 
significantly lower than that of the PI group by approximately 9 years; [F(2,58) = 
3.518, p = .036]. Given that age may be a confounding variable, subsequent 
hypothesis-testing analyses were performed first without a covariate (ANOVA) and 
then again with age as a covariate (ANCOVA). 
 
With regards to participants sleep characteristics Table 1 shows that there were no 
significant differences between the PI and IdI groups on either the PSQI [t (38) = -
.231, p = .818] or the ISI [t(38) = -1.25, p = .22]. The mean scores obtained on these 
measures are indicative of a clinical insomnia difficulty of moderate severity and as 
such validated the allocation of participants to each of the insomnia groups. Group 
allocation was also supported by the IdI group reporting significantly lower mean age 
of insomnia onset and greater periods of insomnia duration and the GS group reporting 
significantly lower levels of sleep effort than the insomnia groups (see Table 2 and 
Table 3). 
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Testing the study hypotheses 
 
Table 2 displays descriptive statistics for all the measures that were utilised for 
hypothesis testing. Notably, Table 2 shows that no significant differences were found 
between the insomnia groups on either the BDI-II or BAI. The mean scores reported 
by both groups on these measures are indicative of mild anxiety and minimal 
depressive symptoms and thus support the inclusion of the participants in the study as 
people who suffer from a primary insomnia disorder rather than insomnia secondary to 
anxiety or depression. 
 
(INSERT TABLE 2 HERE) 
 
Primary Hypotheses 
 
Hypothesis 1: Participants with PI will report greater levels of BIS sensitivity than 
normal sleepers and those with IdI 
It can be seen from Table 2 that the PI group reported greater levels of BIS sensitivity 
than both the GS and IdI groups with the IdI group reporting the lowest mean BIS 
scale score of all the groups. A one-way ANOVA and post-hoc Bonferroni procedure 
[p<.05] to correct for multiple comparisons showed this difference to be significant [F 
(2,58) = 7.95, p = .001] thus supporting Hypothesis 1. The ANCOVA model with age 
entered as a covariate showed that age did not affect these results [F (2,58) = 7.79, p = 
.001]. The significant difference in BIS sensitivity found between the PI and IdI 
groups represents a standardised effect size of d= 1.28 which in accordance with 
Cohen’s (1988) conventions equates to a large effect. 
 
Hypothesis 2: Participants with PI will report lower levels of BAS sensitivity than 
normal sleepers. 
There were no significant differences found between the PI and GS groups on any of 
the BAS measures: BAS Drive (F (2,58) = .50, p = .609); Bas Fun Seeking (F (2,58) = 
1.24, p = .296); BAS Reward Responsiveness (F (2,58) = .12, p = .884) therefore 
Hypothesis 2 was not supported. 
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Hypothesis 3: Participants with IdI will report greater levels of BAS sensitivity than 
those with PI. 
This hypothesis was also not supported as no significant differences were found 
between the PI and IdI groups on any of the BAS measures (see analyses above). 
However, the difference between the insomnia groups means on the BAS Fun Seeking 
Scale was 1.25 (approaching half a standard deviation). Therefore, a retrospective 
power calculation was performed to find out what sample size would be required to 
detect a meaningful difference if it was present. This calculation indicated that a 
sample size of 79 participants in each group would be required at an alpha level of 
0.05 with power of 0.8 (two- tailed). 
 
Table 3 below presents means and standard deviations for the BIS/BAS scales 
collected from a large Australian community sample (Jorm et al., 1999) along with 
those from the current study. It can be seen that the GS group reported BIS/BAS 
scores that are much in line with those of the community norms, thus further 
supporting their inclusion in the study. The BAS scales scores reported by the PI and 
IdI groups are also comparable to the community norms. However, the mean BIS score 
of the PI group is somewhat higher than that of the community sample norms for 
females and males of the same age range, whereas the IdI group’s mean BIS score is 
lower. 
 
(INSERT TABLE 3 HERE) 
 
Secondary hypotheses 
 
Hypothesis 4: Participants with PI will report greater levels of overall Sleep Effort 
than those with IdI and will differ in terms of their responses to individual GSES items 
relating to different core components of the sleep effort construct. 
This hypothesis was addressed first in relation to the global construct of sleep effort as 
measured by the GSES total scale score. Table 2 shows that whilst the PI group did 
appear to report greater levels of sleep effort than the IdI group (mean difference = 1.2 
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representing nearly half a standard deviation), this difference was not statistically 
significant on post hoc testing. The overall highly significant ANOVA indicated only 
that the GS group reported much less sleep effort than the insomnia groups (F (2,58) = 
30.77, p<.001). Correlation analyses showed that age was negatively correlated with 
sleep effort in both the PI and IdI groups but the relationship was weak in the PI group 
[r (20) = -.18; R2  = .03, p = .44] and marginally significant in the IdI group [r (20) = -
.46; R2  = .21, p = .04]. As mentioned previously the GSES comprises seven items that 
each relate to different components of Broomfield & Espie’s (2005) sleep effort 
construct and Espie et al’s., (2006) A.I.E. pathway model of insomnia. Accordingly, 
further comparisons were performed at the item level of the GSES. In light of the 
results of the correlation analyses age was also incorporated as a covariate within the 
MANCOVA model that was applied. The results of the analysis are presented in Table 
4. The omnibus test was significant [F (1,38) = 3.40, p = .008] with subsequent 
univariate analyses revealing significant differences between the PI and IdI groups on 
4 of the 7 GSES items (see Table 4). 
 
(INSERT TABLE 4 HERE) 
 
Hypothesis 5: Participants with PI who report greater levels of psychopathology will 
also report greater levels of BIS sensitivity. 
 
Pearson correlation coefficients were calculated to investigate the relationships 
between reported levels of depression (BDI II) and anxiety (BAI) and BIS sensitivity 
among the participants in the PI group. These revealed a significant relationship 
between depression and BIS sensitivity [r (20) = .53; R2  = .28, p = .016] but not 
between anxiety level and BIS sensitivity [r (20) = .39;R2  = .15, p = .082]. These 
results partially support hypothesis 5. Given the results of the correlation analyses we 
retested the previously found significant difference between the PI and IdI groups on 
BIS sensitivity with depression and anxiety entered as covariates. The ANCOVA 
showed that the between group difference remained significant when variability in 
depression and anxiety was accounted for [F (1,38) = 14.16, p = .001]. 
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DISCUSSION 
 
Few previous studies have investigated Idiopathic Insomnia or compared it with 
Psychophysiological Insomnia using robust diagnostic criteria. In addition, the 
potential relationships between primary insomnia and Gray’s (1987, 1994) 
hypothesised neurobiological motivational systems have not previously been explored. 
Accordingly, the present study aimed to extend our knowledge of the PI and IdI 
insomnia subtypes by comparing self-report measures of BIS/BAS sensitivity, sleep 
effort, anxiety and depression amongst adults who met diagnostic criteria for PI, IdI, 
and normal sleep. The main results will be discussed before the strengths, limitations 
and implications of the study are examined. 
 
Insomnia and BIS/BAS Sensitivity 
The findings in relation to the study’s primary research questions and first three 
tentative hypotheses were mixed with only the hypothesis relating to BIS sensitivity 
receiving clear support. As predicted by hypothesis 1 the PI group reported 
significantly greater levels of BIS sensitivity than the GS and IdI group, with the IdI 
group surprisingly reporting the lowest levels of any of the groups. This suggests 
firstly that sensitivity to potential threat related stimuli may indeed play a role in 
disrupting the sleep wake process and may at least partly drive the excessive attention 
to and worry and anxiety about sleep that is associated with the development and 
maintenance of PI. Secondly, this finding also suggests that those with IdI may be less 
sensitive to sleep-related threat stimuli than people with PI and that despite the lifelong 
duration and largely unremitting pattern of their insomnia complaint they are more like 
those without a sleep problem in this respect. 
 
The initial analyses did not support hypotheses 2 and 3 as no significant differences 
were found between any of the groups on the 3 BAS scales. However, the 
retrospective power analysis performed on the difference between the insomnia groups 
on the BAS Fun Seeking scale showed that a sample size of around only 80 
participants in each group would be required to detect a meaningful difference on this 
measure. As the sample size in the present study was relatively small it may be that the 
56 
study was underpowered to detect any between-group differences on the BAS 
measures should they have been present. 
 
Turning to how the BIS/BAS results compare with previous research using the 
BIS/BAS scales. Comparison with the community norms from Jorm et al, (1999) 
suggests that despite the current sample size being relatively small, the BAS scores 
reported by each of the groups are similar to those that might be found in the wider 
population. However, the BIS scores of the PI and IdI groups were different to those of 
the community norms with the PI group’s being greater and the IdI group’s lower. The 
pattern of BIS/BAS results observed in the PI group is similar to that found by 
previous research relating to anxiety and BIS/BAS sensitivity as described in a recent 
review by Bijttebier et al., (2009). They outline consistent evidence that participants 
with anxiety symptoms often show associations with high BIS sensitivity and report 
levels of BAS sensitivity that show no or only weak relationships with their anxiety 
symptoms and tend not to differ much from those of normal controls. This of course 
lends weight to Gray’s (1987, 1994) belief that the BIS underlies our experiences of 
anxiety. Similarly, as both anxiety and PI are thought to be driven by arousal of 
physiological systems and attention biases toward threatening stimuli, the pattern 
found in the present study could be seen as supporting the hypothesis that increased 
BIS sensitivity may also underlie PI. In addition, the fact that the PI group in this study 
reported only mild levels of anxiety, and no relationship was found between anxiety 
and BIS levels, suggests that the measures employed are tapping into distinct 
constructs and also that participants’ insomnia symptoms could not easily be 
accounted for by anxiety alone. 
 
Sleep Effort 
The findings in relation to sleep effort were consistent with that of Broomfield and 
Espie (2005) with higher levels being reported by those with insomnia compared with 
normal sleepers. This lends support to those models of insomnia, and particularly the 
A.I.E. pathway model (Espie et al., 2006), which site sleep effort as being involved in 
the development and/or maintenance of PI. 
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With regards to the differences in sleep effort observed between the insomnia groups. 
Although the PI group reported higher levels than the IdI group the primary analysis of 
this difference indicated that it was not statistically significant, thus it initially 
appeared that hypothesis 4 was not supported. However, further testing at both the 
overall scale and item levels of the GSES revealed significant differences between the 
insomnia groups when age was included as a covariate. Given that the PI and IdI 
groups did not significantly differ in age this result might at first seem somewhat 
incongruent. However, perhaps less so when viewed within the context of IdI being a 
lifelong sleep difficulty and age therefore largely equating to insomnia duration in IdI. 
It may be that as a person with IdI becomes older they expend less effort on trying to 
find sleep when a lifetime of experience has shown them that these efforts will largely 
go unrewarded. This supposition is supported by the findings that age and sleep effort 
were negatively correlated in the IdI group and that the only item of the GSES on 
which the IdI reported greater scores on than the PI group was item 5 - “I am no good 
at sleeping”. For people with IdI this item may reflect a statement of fact rather than a 
concern relating to a current sleep difficulty as it perhaps is for those with the type of 
insomnia complaint that is often described by those with PI. 
 
Interestingly, the PI group also reported a mean duration of insomnia (16yrs) that 
would indicate that this was a sample of people of whom many would also have had a 
lengthy history of seeing their efforts to sleep going unrewarded. Despite this, they 
reported greater mean scores than the IdI group on all items of the GSES, apart from 
item 5, with the difference reaching statistical significance in the case of 3 of the items. 
These findings are consistent with those of Barrie and Espie (2009) which indicated 
that those with IdI perceive their insomnia to be more permanent and unchangeable in 
nature than those with PI who may tend to view it as a problem that they have some 
influence over and can be solved. This also lends support to Barrie and Espie’s 
suggestion that an acceptance based treatment approach may be more appropriate for 
IdI patients than CBT for insomnia which aims to actively treat and reduce sleep 
problems rather than foster acceptance of them as a chronic condition that the sufferer 
cannot positively influence to any great extent. 
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BIS Sensitivity and Psychopathology 
Hypothesis 5 was partially supported by the finding of a significant positive 
correlation between depression level and BIS sensitivity in the PI group and this 
reflects previous research in which depression has been positively associated with 
higher BIS levels (e.g., Beevers & Meyer, 2002; Campbell-Sills et al., 2004; Jorm et 
al.,1999; Kasch et al., 2002). However, after reviewing the literature Bijttebier et al., 
(2009) concluded that whilst high BIS sensitivity should be considered as a common 
factor to emotional problems like depression and anxiety through its link with negative 
affectivity, the association between high BIS and depression is not consistently found 
and it is weak BAS sensitivity that appears to represent the trait vulnerability factor to 
this disorder through its association with low levels of positive affectivity. The levels 
of depressive symptoms found in the present study were minimal and not indicative of 
the presence of a depressive disorder. In addition, the BAS levels reported were similar 
to that of community norms and thus greater than those usually associated with 
depression. Also, post-hoc analyses showed that variance in reported depression or 
anxiety did not account for the difference found between the PI and IdI groups on BIS 
sensitivity. When viewed together this pattern of results could be interpreted as lending 
support to the suggestion that BIS sensitivity may an important underlying construct in 
the development and maintenance of PI. 
 
Strengths and Limitations 
The principal strength of this study was that the participants were recruited to each 
group using well defined and strict diagnostic criteria and appropriate assessment 
methods to discern these criteria and in particular taking a detailed history of when 
each participant’s insomnia complaint had emerged and how it had developed over 
time. This was supported by findings which showed clear differentiation of the groups 
on several of the measures employed. This adds to Barrie and Espie’s (2009) recent 
findings in providing empirical support for distinguishing between the PI and IdI 
subtypes in both research and clinical practice and is consistent with the practices 
recommended by the AASM (Edinger, J.D., Bonnet, M.H., Bootzin, R.R., Doghramji, 
K., Dorsey, C.M., Espie, C.A. et al., 2004). It is worth noting that the identification of 
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participants as meeting the criteria for IdI was not as problematic as previous literature 
would suggest thus raising the question of why this subtype of primary insomnia has 
not received more attention in the past.  
 
The study does have some limitations which might limit the generalisation of the 
findings beyond the current sample. Firstly, although the study was comprised of a 
well defined sample, due to the relatively small sample size recruited the study may 
have been vulnerable to Type II error. As this was an exploratory study there was 
limited information for determining a sample size which would ensure that any 
significant differences between the groups would be detected. In addition, the 
retrospective power calculation performed suggested that a significant result may have 
been found in relation to the BAS Fun Seeking scale had the obtained sample been 
larger. Accordingly, this study provides some guidance for future research in relation 
to desirable sample size. 
 
Secondly, as the study exclusively employed self-report measures within a cross-
sectional design we cannot make any clear inferences about possible cause and effect 
relationships between any of the variables measured. Future research could employ 
objective measures of sleep and arousal in both the assessment of potential participants 
and measurement of outcome variables. For example, it might be advantageous to be 
able to compare BIS/BAS sensitivity with objective measures of physiological arousal 
and attention bias across well defined groups of participants with PI and IdI. In 
addition, future research could employ prospective study designs to explore the 
relationships between BIS/BAS sensitivity and insomnia over time and thus be able to 
perhaps shed more light on potential causal relationships and how BIS/BAS sensitivity 
relates to peoples’ experience of changes in their insomnia such as periods of 
remission and relapse. 
 
Thirdly, it was decided not to have the GS participants complete the anxiety and 
depression measures in order to encourage willingness to participate in the study by 
minimising the amount of effort and time their participation would involve. In 
hindsight this may have been an error and it would perhaps have been advantageous to 
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have had the GS participants also complete these measures for the purposes of 
comparison and to further validate their inclusion in the study. This may have been 
particularly relevant to comparisons between the GS and IdI groups given that those 
with IdI are thought to typically show only minor psychological abnormalities and in 
this particular study the IdI group’s BIS scores indicated that they may be similar to 
those without a sleep problem in terms of sensitivity to threat related stimuli. 
Accordingly, had the GS group been found to report similar levels of anxiety and 
depression symptoms as the IdI group, this could have provided further evidence in 
support of the supposition that the basis of IdI is more physiological than 
psychological. 
 
Implications 
The findings obtained in this study have potentially important implications for both the 
treatment of primary insomnia and its subtypes and the study of these in research. The 
study was able to identify and clearly differentiate between people with PI and IdI and 
the differences found on the measures of BIS/BAS sensitivity and sleep effort suggest 
that there may be differences in treatment suitability for these insomnia subtypes. 
These findings could be interpreted as suggesting that those with PI may be best suited 
to a treatment approach such as CBTi which seeks to target and moderate 
psychological factors relating to poor sleep and insomnia. This is in line with the 
available treatment research evidence which shows that cognitive-behavioural 
approaches can offer significant benefits to insomnia sufferers (see Morin et al., 2006 
and Riemann & Perlis, 2009). 
 
By contrast the pattern of results found in the IdI group might be seen as suggesting 
that people with this condition may be more suited to an acceptance based approach 
that aims to foster acceptance and appropriate management of what appears to be a 
lifelong and generally unremitting chronic sleep difficulty. This echoes the findings 
and suggestions of Barrie and Espie (2009). Future research could explore whether 
acceptance based interventions and/or mindfulness based techniques could be of 
benefit to people with IdI and help to reduce the impact of their chronic sleep problem 
on their daily lives. 
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With regard to the implications for researchers, the present study provides additional 
evidence for the need to differentiate between different insomnia subtypes and utilize 
appropriate diagnostic criteria and assessment procedures, particularly in clinical trials 
where the efficacy of psychological interventions are being investigated. This is 
particularly important to the validity and comparability of research findings across 
studies and also has implications for epidemiological research. The findings of the 
study might also be seen to have implications for the further development of cognitive, 
neurocognitive and psychobiological models and how these could be incorporated into 
transdiagnostic conceptualisations of psychopathology. 
 
Conclusions 
Despite some limitations the present study met its primary aim of extending our 
knowledge of PI and IdI by investigating the potential role of Gray’s neurobiological 
motivational systems in primary insomnia via self-report measures relating to sleep 
and BIS/BAS sensitivity. The findings showed that those with PI reported greater 
levels of BIS sensitivity than both good sleepers and those with IdI thus suggesting 
that sensitivity to threat may play a role in PI but not necessarily in IdI. This taken 
with the findings relating to sleep effort could be interpreted as offering support to 
models of insomnia which implicate arousal of physiological systems, attention bias 
toward threat stimuli and effortful attempts to control the sleep-wake process in the 
development and/or maintenance of PI. Future research could employ objective 
measures of sleep, physiological arousal and attention bias to explore the potential 
relationships between these objective measures and BIS/BAS sensitivity in primary 
insomnia and its subtypes. 
 
Overall, and perhaps most importantly, the results support the need to differentiate 
between the PI and IdI subtypes in research and clinical practice whilst also lending 
some further support to the view that IdI is more physiological in origin than PI which 
seems to be more clearly associated with both physiological and psychological 
processes. 
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Table 1: Sample Demographics and Sleep Measures 
 
Key: GS = Good Sleepers; PI = Psychophysiological Insomnia; IdI = Idiopathic Insomnia 
 GS 
(n=21) 
M (SD) 
PI 
(n=20) 
M (SD) 
IdI 
(n=20) 
M (SD) 
F (2,58) / t (38) / 
x² (2) 
p value post-hoc 
 
   
   
Age (years) 40.24 (8.1) 49.95 (12.7) 42.15 (15.4) 3.518 .036 GS<PI=IdI 
  
N (%) 
 
N (%) 
 
N (%) 
   
Gender: 
Female 
Male 
 
15 (71.4) 
6 (28.6) 
 
15 (75) 
5 (25) 
 
14 (70) 
6 (30) 
.132 .936 
 
 
      
 M (SD) M (SD) M (SD)    
Age of Onset n/a 34.33 (13.8) 4.7 (4.1) -9.18 <.001  
Insomnia 
Duration n/a 16.33 (11.0) 37.15 (14.2) 5.01 <.001 
 
ISI n/a 17.39 (4.67) 15.25 (5.77) -1.25 .22  
PSQI n/a 13.11 (2.95) 12.85 (3.88) -.231 .818  
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  Table 2: Hypotheses Testing Measures 
 
   Key: GS = Good Sleepers; PI = Psychophysiological Insomnia; IdI = Idiopathic Insomnia 
 
 GS 
(n=21) 
M (SD) 
PI 
(n=20) 
M (SD) 
IdI 
(n=20) 
M (SD) 
F (2,58) / t (df38) p value post-hoc 
BIS 20.71 (3.41) 22.85 (2.71) 18.65 (3.77) 7.95 .001 PI>IdI=GS 
BAS DRIVE 9.57 (2.39) 10.25 (2.93) 9.5 (2.52) .500 .609  
BAS FUN 11.28 (1.87) 10.60 (2.74) 11.85 (2.83) 1.243 .296  
BAS 
REWARD 15.67 (1.77) 15.95 (2.01) 16.0 (3.03) .123 .884  
 
 
      
GSES 2.0 (1.58) 7.5 (3.0) 6.3 (2.34) 30.77 <.001 GS<PI=IdI 
BDI II n/a 9.6 (6.64) 5.65 (7.24) -1.8 .08  
BAI n/a 12.75 (11.12) 8.2 (7.46) -1.52 .137  
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Table 3: Means & Standard Deviations for the BIS/BAS Scales from a large community sample and the current sample 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sample Type & Source BIS BAS DRIVE BAS FUN BAS REWARD 
Community Sample  
Female - Age 40 to 49yrs (n = 393) 
From Jorm et al. (1999) 
21.4 (3.4) 9.8 (2.7) 10.8 (2.3) 16.8 (2.0) 
 
    
Community Sample  
Male - Age 40 to 49yrs (n = 336) 
From Jorm et al. (1999) 
20.0 (3.7) 10.3 (2.4) 10.6 (2.2) 16.1 (2.1) 
 
    
Current Sample - GS Group  
(Mean Age = 40.24, SD = 8.1) 20.71 (3.41) 9.57 (2.39) 11.28 (1.87) 15.67 (1.77) 
 
    
Current Sample - PI Group 
(Mean Age = 49.95.24, SD = 12.7) 22.85 (2.71) 10.25 (2.93) 10.60 (2.74) 15.95 (2.01) 
 
    
Current Sample - IdI Group 
(Mean Age = 42.15, SD = 15.4) 18.65 (3.77) 9.5 (2.52) 11.85 (2.83) 16.0 (3.03) 
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Table 4 Glasgow Sleep Effort Scale Item Analyses 
 
Key: GS = Good Sleepers; PI = Psychophysiological Insomnia; IdI = Idiopathic Insomnia 
Item/Statement M (SD) F (1, 38) p value post-hoc 
1. I put too much effort into sleeping when it should come naturally 
GS =  .14 
PI = 1.10 
IdI =  .70 
16.78 <.001 PI>IdI>GS 
2. I feel I should be able to control my sleep 
GS =  .67 
PI = 1.15 
IdI =  .90 
3.754 .029 GS<PI=IdI 
3. I put off going to bed at night for fear of not being able to sleep 
GS = .00 
PI =  .50 
IdI =  .75 
10.711 <.001 GS<PI=IdI 
4. I worry about not sleeping if I cannot sleep 
GS =  .67 
PI =  1.35 
IdI = 1.05 
6.738 .002 GS<PI=IdI 
5. I am no good at sleeping 
GS =  .00 
PI =  1.20 
IdI = 1.70 
57.252 <.001 IdI>PI>GS 
6. I get anxious about sleeping before I go to bed 
GS = .00 
PI =   .80 
IdI = .30 
13.682 <.001 PI>IdI=GS 
7. I worry about the consequences of not sleeping 
GS = .52 
PI = 1.40 
IdI = .90 
10.737 <.001 PI>IdI>GS 
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Figure 1. The Behavioural Inhibition System postulated by Gray (1982) 
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Figure 2. The Behavioural Inhibition System postulated by Gray (1982) and how it might relate to the experience of poor sleep and insomnia 
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Abstract 
 
This reflective account focuses on my experience of a risk assessment appointment 
within a multi-disciplinary Child and Adolescent Mental Health Service that I found to 
be extremely demanding and emotionally challenging. It makes use of models of 
reflective practice from Gibbs (1988) and Johns & Graham (1996) to structure my 
understanding of the experience as a key event in my development as a reflective 
practitioner. The account starts with the professional and personal context in which the 
learning experience took place before going on to describe the experience and the 
feelings I encountered during it and afterward. It then outlines how I went on to process 
and evaluate the experience within the context of my personal and clinical development 
and further training needs. 
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Abstract 
 
This account focuses on my experiences within a service for people experiencing First 
Episode Psychosis and uses elements of Gibbs’ (1988) model of reflective practice to 
reflect upon these as a learning experience in my development as a Clinical 
Psychologist. The account begins by introducing the service based and personal 
context of the learning experience which included joining a service that was about to 
see a significant reduction in the number of psychologists it had available to it. It then 
goes on to explore how I felt about the situation and how I came to came to process 
and manage it through reflective practice. Finally, it outlines the positive outcomes of 
the experience in terms of my clinical and professional development.
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Appendix A.2: Systematic Review - Study Evaluation Tool 
 
Study No.  
Study title: 
 
 
 
 
Journal title: 
 
 
Year of publication: 
 
 
First author: 
 
 
Study Design: 
 
 
Participant characteristics: 
 
 
 
Types of groups included in the study. For 
example, Primary Insomnia, Normal Sleepers 
etc. 
 
 
 
Intervention/treatment mode: 
 
 
 
Does the paper specifically refer to which 
diagnostic criteria were employed in the 
study? 
 
 
 
 
 DSM IV                                    ICSD                                  AASM RDC  
 
Other (Specify): 
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What inclusion and exclusion criteria are 
actually listed in the paper? 
 
 
 
 
Do the criteria employed correspond to the 
RDC for Insomnia Disorder? 
 
 YES                         PARTIALLY                                 NO 
 
Where specific insomnia subtypes were being 
studied were appropriate RDC for these 
subtypes utilised? If yes which ones? For 
example Idiopathic Insomnia. 
 
 YES                         PARTIALLY                     Not Applicable 
 
Subtypes utilised: 
 
 
 
Were participants further categorised 
according to the pattern of their insomnia 
problem i.e. Sleep Onset difficulty or Waking 
After Sleep difficulty? If yes which categories 
were used? 
 
 
 YES     NO 
 
 Sleep Onset                                Waking After Sleep   Mixed 
 
Which methods of assessment were reportedly employed to identify participants who met the criteria employed?: 
 
Item 12. Clinical Interview              Yes (2 points) No (0 points)  Structured or Semi-structured (2pts) Unstructured (1pt)
 DK (0) 
Item 13. Were independent interviewers used?   Yes (2 points)  No (0 points) 
Item 14. Was inter-rater reliability checked?  Yes (2 points)  No (0 points) 
Item 15. Were Polysomnography data collected? Yes (2 points)  No (0 points) 
Item 16. Were Sleep Diary/Log data collected?  Yes (2 points)  No (0 points) 
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Other assessment procedures utilised? (specify): 
               Section Total Score: 
 
Was the following information reported by the researchers? 
 
Item 17. Recruitment methods employed  Yes (2 points)  No (0 points) 
Item 18. Types of individuals enrolled i.e. clinical or volunteer participants?  Yes (2 points)  No (0 points) 
Item 19. Means, std deviations and ranges of sleep measures e.g. TST, SOL, WASO, SE?  Yes (2 points)  Partially (1 point) No 
(0 points) 
Item 20. Means, std deviations and distribution of insomnia duration?  Yes (2 points)  Partially (1 point) No (0 points) 
Item 21. Means and distribution of insomnia frequency?  Yes (2 points)  Partially (1 point) No (0 points) 
Item 22. Means and std deviations of discrepancies between subjective estimates and objective measures of sleep measures? 
 Yes (2 points)  Partially (1 point) No (0 points)  Not Applicable (2 points) 
               Section Total Score: 
 
 
What were the main findings of the study in relation to the psychological interventions employed? 
 
 
 
 
 
Notes 
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indicated. Authors should avoid abbreviations (except for those commonly 
understood), long sentences, and many juxtaposed numbers in sentences. 
 
References 
References cited in the text should include the author's name and year of publication. 
Where there are more than two authors, list the first author only, followed by et al. 
Reference list entries should be alphabetized by the last name of the first author of 
each publication. For publications with six or less authors, list the last name and 
initials for all authors. For publications with more than six authors, list the first three 
authors and then use et al. after the third author's name to indicate the rest of the 
authors. Provide article title, source, year of publication, volume, and inclusive pages. 
Note that periods should be included as part of authors' initials and journal 
abbreviations as required, and at the end of a reference entry. A list of abbreviations 
of journal names is offered by the US National Library of Medicine (NLM) 
(ftp://nlmpubs.nlm.nih.gov/online/journals/ljiweb.pdf) and in the Journal Database of 
PubMed (http://www.ncbi.nlm.nih.gov/sites/entrez?db=journals). 
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Abstract 
 
Background: Insomnia is the most widely prevalent disorder of sleep, affecting 6 to 
38% of adults. There has long been debate around how insomnia should be 
conceptualised, diagnosed and treated. Further research into identifying the 
mechanisms that underlie the development and maintenance of insomnia and its 
different subtypes is required. Neurophysiological self-regulatory behaviour systems 
have been implicated in the etiology of a variety of other psychiatric disorders, 
however, it is not known what role they might play in the development and 
maintenance of insomnia. 
 
Aims: The proposed study aims to investigate the potential role of self-regulatory 
behaviour systems in the development and maintenance of Psychophysiological 
Insomnia (PI) and Idiopathic Insomnia (IdI) among a sample of adults. 
 
Methods: Groups of participants with PI and IdI, and Good Sleepers, will complete 
self-report measures of Behavioural Inhibition Sensitivity, Behavioural Activation 
Sensitivity, Sleep Effort, Depression and Anxiety. Analyses of variance (ANOVA) 
and covariance (ANCOVA) will determine any between group differences and 
moderating effects of psychopathology. 
 
Applications: Despite differences in clinical presentation and response to standard 
treatment, patients with PI and IdI are managed by clinicians in the same way. The 
proposed study will further consider how the PI and IdI subtypes differ. The findings 
may have implications for how treatment protocols could be further developed for 
use with persons presenting with different insomnia subtypes. 
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1. Introduction 
 
1.1  Insomnia 
 
Insomnia is a common problem which is thought to affect from 6-38% of adults 1. 
However, it is poorly understood and frequently viewed by clinicians as merely a 
symptom of so-called ‘primary’ disorders rather than a clinical disorder in its own 
right. Consequently, insomnia symptoms can go untreated in favour of targeting the 
‘primary’ disorder 2. In addition, despite differences in the characteristics and 
treatability of different insomnia subtypes, they are usually managed in the same 
way. The International Classification of Sleep Disorders, 2nd Edition (ICSD-2), 3 lists 
diagnostic criteria for 3 primary insomnia subtypes; Psychophysiological Insomnia, 
Idiopathic Insomnia and Paradoxical Insomnia. The proposed study aims to 
investigate the first and second of these subtypes. 
 
1.1.2 Psychophysiological Insomnia 
 
Psychophysiological Insomnia (PI), is found in 1-2% of the general population, and 
12-15% of those presenting for treatment 4. It develops in adulthood, can often be 
linked to identifiable precipitating events and/or stressors, and comprises both 
psychological and physiological features such as conditioned arousal, sleep-
incompatible behaviour, sleep preoccupation, and excessive focus on and anxiety 
about sleep 2. Research literature has demonstrated that PI can be treated effectively 
using psychological interventions (e.g. Cognitive Behaviour Therapy for Insomnia) 
thus suggesting that behavioural and cognitive factors play a part in PI. 
 
Research into the psychological mechanisms implicated in the development and 
maintenance of PI has resulted in a number of explanatory models being put forward 
5
. The proposed study will focus on the Attention-Intention-Effort (A-I-E) pathway 
model of PI development proposed by Espie et al. 5. They posit that the primarily 
self-regulatory sleep-wake process is disrupted by selectively attending to sleep, 
explicitly intending to sleep, and by making effortful attempts to initiate sleep, 
leading to the development of PI. This model mirrors that of other psychological 
disorders, (i.e. Depression & Anxiety) that also cite attention biases as being 
involved in etiology. 
 
1.1.3 Idiopathic Insomnia 
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Few studies have investigated the nature of Idiopathic Insomnia (IdI), also known as 
Childhood Onset Insomnia, and it has proved to be a conceptually difficult disorder 
to define and research. The ICSD-2 describes IdI as a longstanding insomnia 
complaint with a chronic and persistent course, few periods of sustained remission, 
and onset during infancy or early childhood. IdI affects around 1% of adults and is 
seen in less than 10% of those presenting with an insomnia complaint 1, 2 Unlike PI, 
there is usually an absence of identifiable precipitating and maintaining factors in the 
history of those with IdI. 
 
IdI patients typically show only minor psychological abnormalities although there is 
limited evidence that some of them adopt denial and repression as coping strategies 
and of an association with neurodevelopmental disorders such as ADHD and 
Dyslexia 6, 7. Edinger et al. 8 found that participants who reported childhood onset 
insomnia had higher levels of arousability and were largely unresponsive to 
behavioural treatment. These findings lend weight to Hauri & Olmstead’s 6 
supposition that IdI may have a less psychological and more neurophysiologcial 
etiology than PI. 
 
1.2 Self-regulatory Behaviour Systems 
 
Motivational theorists argue that a continual process of moving toward, and away 
from, mental goal representations underlies human behaviour 9. Put simply, the 
model proposes that human behaviour is motivated by the pursuit of desirable goals 
and pleasure, and the avoidance of negative outcomes and displeasure. Gray 10, 11 
endorses this view and suggests that two general motivational systems regulate 
behaviour and affect; a Behavioural Inhibition System (BIS) and a Behavioural 
Activation System (BAS). 
 
The BIS is said to be involved in the experience of negative affect, and the 
anticipation and avoidance of threat and negative outcomes. Indeed, Gray has argued 
that this mechanism underlies the experience of anxiety 10, 11. The BAS, is thought to 
control appetitive motivation and to be sensitive to signals of reward. It is therefore 
implicated in the experience of positive affect, and the facilitation of behaviour that 
might lead to positive outcomes. 
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Research has shown that when threat occurs individuals high in BIS sensitivity 
become more anxious, distressed, and avoidant than persons lower in BIS sensitivity. 
Conversely, when potential reward arises, those high in BAS sensitivity tend to 
experience more positive affect and engage in more approach behaviour than those 
lower in BAS sensitivity. Low levels of BAS sensitivity have also been associated 
with negative affect suggesting that high levels of BAS sensitivity may be protective 
12-15
. 
 
1.3 The role of Self-regulatory Behaviour Systems in Insomnia 
 
Attentional biases and there relationship with affect and behaviour are central to the 
A.I.E. pathway model of PI and self-regulatory behaviour system models. Both 
insomnia and differing levels of BIS/BAS sensitivity have also been associated with 
psychopathology. Therefore, it would seem reasonable to hypothesize that differing 
levels of BIS/BAS sensitivity might be found between those with PI and healthy 
normal sleepers. For example, would greater levels of BIS sensitivity be found 
among those with PI and greater levels of BAS sensitivity in normal sleepers? 
 
It is also possible that BIS/BAS sensitivity may be related to the difference in some 
characteristics of PI and IdI. For example, as higher levels of BAS sensitivity are 
thought to be protective of psychological wellbeing, might people with IdI, report 
greater levels of BAS sensitivity than those with PI who often present with 
psychological distress. 
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2. Aims and Hypotheses 
 
2.1 Aims 
 
The proposed study aims to extend our knowledge of insomnia subtypes by 
measuring self-reported BIS/BAS sensitivity amongst adults who meet criteria for PI 
and IdI, and normal sleep. Given that sleep effort is said to play a key part in PI, but 
its role in IdI is unknown, it will also measure levels of sleep effort. Additionally, it 
is proposed to take measures of depression and anxiety to investigate the relationship 
between insomnia and psychopathology and BIS/BAS sensitivity. The inclusion of 
participants with PI and IdI will compliment other research into these subtypes that is 
being carried out within the University of Glasgow Sleep Centre (UGSC). 
 
Specifically, it aims to address the following research questions: 
 
Primary questions: 
 
5. Do those with PI and IdI report differing levels of BIS/BAS sensitivity 
compared to good sleepers? 
6. Do those with PI report differing levels of BIS/BAS sensitivity compared to 
those with IdI? 
 
Secondary questions: 
7. Do those with PI report differing levels of Sleep Effort compared to those 
with IdI? 
8. What are the relationships between BIS/BAS sensitivity and Sleep Effort in 
those with PI and IdI? 
9. Do Anxiety and Depression moderate the relationships between PI, IdI, 
BIS/BAS sensitivity and Sleep Effort? 
 
2.2 Hypotheses 
Given the exploratory nature of the proposed study, the following tentative 
hypotheses are proposed: 
 
6. Participants with PI will report greater levels of BIS sensitivity than normal 
sleepers. 
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7. Participants with PI will report lower levels of BAS sensitivity than normal 
sleepers. 
8. Participants with IdI will report greater levels of BAS sensitivity than those 
with PI. 
9. Participants with PI will report greater levels of Sleep Effort than those with 
IdI 
10. Participants with PI who report greater levels of psychopathology will also 
report greater levels of BIS sensitivity. 
 
3. Plan of Investigation 
 
3.1 Participants 
 
Participants will be 18 years of age or over. There will be a PI group, IdI group, and 
Good Sleeper (GS) group. 
 
3.1.1 Inclusion and Exclusion Criteria 
 
Participants in the PI and IdI groups will meet sleep disturbance criteria as indicated 
by scores of >5 on the Pittsburgh Sleep Quality Index (PSQI) and > 14 (Moderate 
Insomnia) on the Insomnia Severity Index (ISI). They will also meet general criteria 
for insomnia and specific criteria for PI and IdI as outlined in the ICSD-2 2. The GS 
group will meet research diagnostic criteria for Normal Sleepers (Controls) 16. 
 
Exclusion criteria will include: 
a. The presence of another sleep disorder such as narcolepsy, sleep apnoea, 
restless legs syndrome, circadian sleep disorders or parasomnias 
b. The presence of severe psychopathological disorder 
c. The presence of a physical/medical disorder which may be influencing sleep 
patterns 
d. Where sleep disturbance is suspected as being the result of substance misuse 
e. Being in receipt of concurrent psychological or pharmacological treatment for 
sleep problems. 
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To ensure a clear distinction between the insomnia groups, the IdI group will be 
required to have developed insomnia by age twelve and the PI group after the age of 
seventeen. 
 
Group allocation shall be verified by individual case reviews with Professor Colin 
Espie, whom is a highly experienced researcher of sleep disorders. Data obtained 
from sleep diaries will assist with confirming group allocation 
 
3.2 Recruitment Procedures 
 
Participants will be recruited using standard UGSC methods, including emails to 
University of Glasgow students and staff, placement of notices in NHS staff 
newsletters; posters in NHS facilities including GP surgeries, newspaper 
advertisements etc, and contacting individuals who have previously participated in 
sleep research and given permission to be contacted for other studies. 
 
3.3 Measures 
 
Participants will complete the following standard self-report questionnaires*, which 
have been found to be reliable and possess appropriate levels of internal consistency: 
 
1) Pittsburgh Sleep Quality Index (PSQI) 17 
2) Insomnia Severity Index (ISI) 18. 
3) Beck Depression Inventory (BDI) 19 
4) Beck Anxiety Inventory (BAI) 20 
5) Behavioural Inhibition Scale (BIS) and Behavioural Activation Scales (BAS) 
12
 The BIS/BAS questionnaire is comprised of 24 items with four subscales: 
One reflects BIS sensitivity (7 items), and three reflect aspects of BAS 
sensitivity: BAS Drive (4 items); BAS Fun Seeking (4 items); and BAS 
Reward Responsiveness (5 items) 
6) Glasgow Sleep Effort Scale (GSES) 21 The GSES is a 7-item scale designed 
to assess effortful preoccupation with sleep. 
 
*Further details of these can be found in Appendix 1 
 
 
 
3.4 Design 
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The study will comprise a quasi-experimental between-groups design with the 
following three groups: 
 
1) Psychophysiological Insomnia (PI) 2) Idiopathic Insomnia (IdI) 
 
3) Good Sleeper (GS) 
 
Efforts will be made to balance the groups in terms of gender and age. 
 
Group will be the main independent variable and participant scores on the PQSI, ISI. 
BIS/BAS sensitivity and Sleep Effort will be the main dependent variables. 
Psychopathology, as measured by the BDI and BAI will be the main secondary 
dependent variables. 
 
3.5 Research Procedures 
 
Potential participants will be invited to contact the researcher/Glasgow Sleep Centre 
by e-mail or telephone. They will be provided with further information regarding the 
study and invited to participate. They will then complete a brief telephone screening 
instrument which is routinely used at the UGSC. Participants meeting criteria for an 
appropriate group will be invited to meet with the researcher at the UGSC to 
complete the self-report measures, a consent form and patient information sheet. 
They will then participate in a clinical interview and assessment which will last about 
1 hour. 
 
Participants will be asked to complete a 7-day sleep diary after meeting the 
researcher, and to return it in the freepost envelope provided. Individuals not meeting 
the criteria for an appropriate group will be debriefed regarding the aims and 
objectives of the study and thanked for their interest. They will also be offered a 
copy of ‘The Good Sleep Guide’, a leaflet providing advice on effective self-help, 
prepared by Professor Colin Espie and recommended by the British Sleep Society. 
 
3.6 Justification of sample size 
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To our knowledge no previous studies have investigated the relationship between 
insomnia and BIS/BAS sensitivity. Therefore it was not possible to calculate the 
optimal sample size required for the proposed study by referring to previous findings 
in this area. In addition, previous research which has investigated psychological 
variables in persons with IdI is extremely limited. However, Hauri & Olmstead’s 6 
did compare adults with childhood and adult onset insomnia using sample sizes of 
n=20 and n=39 respectively, and found significant differences between the groups on 
sleep related characteristics. More recently, an as yet unpublished study which 
investigated the role of acceptance and coping style in IdI and PI was completed 
within the UGSC. In accordance with the relevant power calculations this study 
included PI, IdI and GS groups with 30 participants in each. 
 
Unfortunately, the majority of previous research utilizing the BIS/BAS scales has 
looked at within group differences in large clinical and non-clinical community 
samples. However, Kasch et al., 15 examined BIS/BAS sensitivity in 62 depressed 
participants and 27 non-depressed controls. They found that the depressed 
participants reported significantly lower levels of BAS and higher levels of BIS. 
Effect sizes (calculated from reported means & standard deviations) were as follows: BIS 
d = 1.12, BAS Drive d = .99, BAS Reward Responsiveness d = .94 and BAS Fun 
Seeking d = .86. In accordance with Cohen’s (1998) effect size conventions such 
figures correspond to large effects. 
 
The proposed study’s primary hypotheses relate to between group differences. Based 
on the effect sizes found by Kasch et al., 15, and the sample sizes employed in 
previous studies of IdI, a large effect size of 0.7 would seem reasonable for the 
proposed investigation. A series of power calculations was conducted using the 
G*Power 3 software program. These revealed that an estimated 24 participants per 
group would be required to detect significant differences at an alpha level of 0.05, 
with power of 0.8 (one tailed). Given that it is intended to use demographically 
matched samples and clearly differentiated experimental groups, it is proposed that a 
sample size of 30 participants per group will be sufficient to detect any differences. 
 
3.7 Settings and Equipment 
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Access to e-mail and telephone facilities will be required for recruitment purposes. 
The UGSC laboratory at the Sackler Institute will provide suitable rooms for 
conducting interviews with participants. 
 
3.8 Data Analysis 
 
Analysis will be conducted using the Statistics Package for the Social Sciences for 
Windows (SPSS for Windows) software package. The data will be checked visually, 
and with reference to skewness and kurtosis values to ensure that they are normally 
distributed. If necessary, the data will be transformed to meet criteria for the use of 
parametric tests. Initial descriptive statistics will then be produced for the purposes of 
sample description. Demographic and sleep related data will be analysed to 
determine any differences between the groups and which variables should be 
included as covariates in further analyses. A series of ANOVAs will be performed to 
identify any between group differences on the main dependent variables. Post-hoc 
testing will be utilized to further analyse these. Within group correlation analyses 
shall also be computed to investigate the relationship between BIS/BAS sensitivity, 
Sleep Effort, Anxiety and Depression in participants with PI and IdI. Should the 
groups differ on measures of anxiety and depression, ANCOVAs will be performed 
to investigate the potential moderating effects of psychopathology. Where necessary, 
corrections will be made for the effects of multiple comparisons. 
 
4. Health and Safety Issues 
 
This study will conform to the standard operating procedures of the UGSC which 
include a comprehensive risk assessment analysis. 
 
4.1 Researcher Safety Issues 
 
The study will adhere to the following procedures to ensure that there are no risks to 
the researcher in conducting this study. Firstly, an email account will be set up for 
the sole purpose of recruitment, thus ensuring that participants do not have access to 
personal information about the researcher. The researcher will meet participants in a 
secure building, and at a time when colleagues are present. 
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4.2 Participant Safety Issues 
 
Participants will be fully briefed on study procedures prior to consent being obtained 
and will be advised that interviews will take place during the day in a secure and 
occupied building. 
 
5. Ethical Issues 
 
Participation will be voluntary and participants will be informed that they are free to 
withdraw from the study at any stage. The proposed research method does not 
require the deception of participants and there are no invasive procedures involved. 
Therefore, it does not appear to pose any foreseeable threat to participants’ 
psychological well-being, health values or dignity. 
 
Methods will be employed to ensure confidentiality during data input and storage of 
data. Following completion of the study participants will be offered the opportunity 
to be provided with a summary of the outcome of the research. 
 
6. Financial Issues 
 
It is anticipated that the cost of questionnaires and administration related costs will 
be covered by the University Section of Psychological Medicine. No equipment 
requires to be purchased for the purposes of the proposed study. The researcher will 
have access to appropriate computer based data analysis software via the Section of 
Psychological Medicine and UGSC. It is envisaged that Greater Glasgow & Clyde 
Research and Development Department will reimburse participant travel costs. 
 
7. Timetable 
 
Ethical approval submission:   September/October 2008 
 
Participant recruitment & data collection: December 2008 to May 2009 
 
Analysis & write up:    May 2009 to August 2009 
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8. Practical Applications 
 
Despite the differences in presentation, diagnostic criteria and variability in 
responses to standard treatment, patients with different subtypes of insomnia are 
usually managed by clinicians in the same way. The proposed study will further 
consider how the PI and IdI subtypes of insomnia differ, and may provide some 
suggestions as to how psychological treatments for insomnia could be further 
developed and utilized more appropriately. 
 
9. Ethical and Management Approval Submissions 
 
Ethical approval will be sought from Greater Glasgow Primary Care Trust Ethics 
Committee and management approval from Greater Glasgow & Clyde Research and 
Development Department. Approval will also be sought from the relevant University 
faculties to contact potential participants within the staff and student body. 
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APPENDIX 1 
 
Participants will complete the following self-report questionnaires: 
 
1) Pittsburgh Sleep Quality Index: The Pittsburgh Sleep Quality Index (PSQI; 
Buysse et al., 1989) provides a reliable, valid and standardized measure of 
sleep quality; to discriminate between good and poor sleepers. A PSQI global 
score >5 indicates that a subject is having severe difficulty in at least two 
areas, or moderate difficulty in more than three areas of sleep quality. Recent, 
independent study has validated this cut off and confirmed reliability 
(Cronbach’s alpha = 0.85, test–retest r = 0.84; Backhaus et al., 2002). 
 
2) Insomnia Severity Index (ISI; Bastien, Vallieres & Morin, 2001) The ISI has 
been reported to be a reliable and valid instrument for reporting perceived 
insomnia severity with an alpha co-efficient of internal consistency of 0.74 
(Bastien, Vallieres & Morin, 2001).  The ISI is a self-report measure, which 
asks the rater to state how severe their insomnia is, how much they feel it, the 
impact it has on their life and how distressed they are by it. Adequate internal 
consistency of this measure has been reported 
 
3) Beck Depression Inventory (BDI; Beck, Steer & Brown, 1996) The BDI is a 
21-item self-report form covering symptoms of depression. It is widely 
accepted that a score of ’23’ or above serves as a measure of severe 
depression. The BDI demonstrates high internal consistency, with alpha 
coefficients of 0.86 and 0.81 for psychiatric and non-psychiatric populations, 
respectively. 
 
4) Beck Anxiety Inventory (BAI; Beck, Epstein, Brown & Steer, 1988) The BAI 
is a 21=item questionnaire that measures the severity of anxiety in adults.  
This measure will therefore be able to identify and exclude participants with 
high levels of anxiety.  It is widely accepted that a score of ’30’ or above 
serves as a measure of severe anxiety.  The psychometric properties of BAI 
have been widely studied, resulting in high internal consistency α = 0.92 and 
excellent test-retest reliability r (81) = 0.75 (Beck, Epstein. Brown & Steer; 
1998). 
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5) Behavioural Inhibition Scale (BIS) and Behavioural Activation Scales (BAS) 
(Carver & White, 1994) Behavioural Inhibition System (BIS) and 
Behavioural Activation System (BAS) Sensitivity. BIS/BAS sensitivity will 
be assessed using the BIS/BAS Scale (Carver & White, 1994) which is 
comprised of 24 items with four subscales: One reflects BIS sensitivity (7 
items), and three reflect aspects of BAS sensitivity: BAS Drive (4 items); 
BAS Fun Seeking (4 items); and BAS Reward Responsiveness (5 items). The 
three aspects of BAS sensitivity derive from diverse theoretical statements 
about how BAS functioning should be reflected experientially. The three 
BAS-related scales were designed to reflect these somewhat distinct functions 
(Carver, Meyer, & Antoni, 2000). Respondents rate each item on a 4-point 
scale ranging from 1 (very true for me) to 4 (very false for me). Higher scores 
on each scale indicate greater levels of BIS/BAS sensitivity. Internal 
consistencies for the BIS/BAS Scales have been found to be adequate: 
Cronbach’s alphas = .79, .72, .69, and .69, for the BIS scale, BAS Drive, 
BAS Fun Seeking, and BAS Reward Responsiveness, respectively 
(O’Connor & Forgan,.2007). In an 8-month follow-up study of both 
depressed and non-depressed individuals, Kasch et al. (2002) found that the 
BIS and BAS scales showed stability over time and changes in participants’ 
clinical state. 
 
6) Glasgow Sleep Effort Scale (GSES; Broomfield & Espie, 2005) The GSES is 
a short (7-item) scale designed to assess effortful preoccupation with sleep. 
This is an important construct within the ICSD-2 definition of PI; and is the 
‘end state’ of the proposed Attention-Intention-Effort pathway. The GSES 
has a single factor structure with acceptable internal consistency (α =.77). 
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Appendix B.3: Diagnostic Criteria for Insomnia Groups and Good Sleepers 
 
Participants in the PI and IdI groups will meet the following general criteria for insomnia as 
outlined in the ICSD-2 diagnostic classification system: 
 
A. A complaint of difficulty initiating sleep, difficulty maintaining sleep, or waking up 
too early or sleep that is chronically non-restorative or poor in quality. 
B. The above sleep difficulty occurs despite adequate opportunity and circumstances 
for sleep. 
C. At least one of the following forms of daytime impairment related to the night time 
sleep difficulty is reported by the patient: 
i. Fatigue or malaise 
ii. Attention, concentration, or ,memory impairment 
iii. Social or vocational dysfunction 
iv. Mood disturbance or irritability 
v. Daytime sleepiness 
vi. Motivation, energy, or initiative reduction 
vii. Proneness for errors or accidents at work or while driving 
viii. Tension, headaches, or gastrointestinal symptoms in response to sleep loss 
ix. Concerns or worries about sleep 
 
Participants eligible for inclusion in the PI group will also meet the following diagnostic 
criteria for Psychophysiological Insomnia: 
 
A. The patient’s symptoms meet the criteria for insomnia 
B. The insomnia is present for at least one month 
C. The patient has evidence of conditioned sleep difficulty and/or heightened arousal in 
bed as indicated by one or more of the following: 
i. Excessive focus on and heightened anxiety about sleep 
ii. Difficulty falling asleep in bed at the desired bedtime or during planned naps, 
but no difficulty falling asleep during other monotonous activities when not 
intending to sleep 
iii. Ability to sleep better away from home than at home 
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iv. Mental arousal in bed characterized either by intrusive thoughts or perceived 
inability to volitionally cease sleep-preventing mental activity 
v. Heightened somatic tension in bed reflected by a perceived inability to relax the 
body sufficiently to allow sleep onset 
D. The sleep disturbance is not better explained by another sleep disorder,  medical 
or neurological disorder, medication use, or substance use disorder. 
 
Participants eligible for inclusion in the IdI group will meet the following diagnostic 
criteria for Idiopathic Insomnia: 
 
A. The patient’s symptoms meet the criteria for insomnia 
B. The course of the disorder is chronic, as indicated by each of the following: 
i. Onset during infancy or childhood 
ii. No identifiable precipitant or cause 
iii. Persistent course with no periods of sustained remission 
C. The sleep disturbance is not better explained by another sleep disorder, medical or 
neurological disorder, medication use, or substance use disorder. 
 
The GS group will meet the following research diagnostic criteria for Normal Sleepers 
(Controls): 
A. The individual has no complaints of sleep disturbance or daytime symptoms 
attributable to unsatisfactory sleep 
B. The individual has a routine standard sleep/wake schedule characterized by regular 
bedtimes and rising times 
C. There is no evidence of a sleep-disruptive medical or mental disorder 
D. There is no evidence of sleep disruption due to a substance exposure, use, abuse, or 
withdrawal 
E. There is no evidence of a primary sleep disorder 
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Appendix B.4: Participant enquiry screening form 
 
Source 
 
How did you find out about the University of 
Glasgow Sleep Centre? 
 
 
 
 
Why have you contacted us?  
 
Method of initial contact (mobile, email, 
office phone)? 
 
 
 
Personal  
 
Full Name: 
 
Date of Birth: Age: 
Telephone: 
 
Alternative Telephone: 
 
When is a good time to call? 
 
 
Address: 
 
What GP practice do you attend, and who is 
the GP you normally see? 
 
 
 
Sleep  
 
Do you have difficulty sleeping at the moment? (Y/N) 
 
 
Have you always been a poor sleeper? (Y/N) 
 
 
How long have you had a sleep problem?(yr)  
Do you have difficulty falling asleep? (Y/N) 
 
 
 
How many nights per week do you have difficulty falling asleep? (out of 7) 
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How long does it normally take you to fall asleep?(min) 
 
 
 
Do you have a difficulty with waking up during the night?(Y/N)  
How many nights per week do you have a difficulty with waking up during the 
night?(out of 7) 
 
How long are you normally awake during the night, in total? (min) 
 
 
What time do you normally go to bed? (time) 
 
 
 
What time do you normally get up?(time) 
 
 
How long do you normally sleep?(hr/min)  
Do you any other difficulties with your sleep (e.g. restless legs, breathing problems, sleep walking)? 
Do you work shifts, night shifts? 
 
 
 
Roughly, how many units of alcohol do you drink per week? 
(Remember: One standard (175ml) glass of wine = 2 unit 
                                   One pint of standard lager = 2.3  units   
                                   Spirit & Mixer   = 1 unit) 
 
 
 
Does your sleep disturbance affect how you feel and function during the day (e.g. 
fatigue, sleepiness, concentration, memory, mood, motivation, irritable, 
work/social functioning etc.).  If yes, specify most salient.  
 
 
 
 
Health 
 
Do you keep in good health physically? (Y/N) 
 
 
What physical health problems do you have (if applicable)? 
 
 
What medicines do you take for your physical health? (if applicable) 
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Do you keep in good health mentally? (Y/N) 
 
 
What mental health problems do you have (if applicable)? 
 
 
What medicines do you take for your mental health? (if applicable) 
 
 
 
Notes 
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Appendix B.5: Participant Information Sheet 
 
 
PARTICIPANT INFORMATION SHEET 
 
The role of behaviour motivation in Adult Onset and Childhood Onset 
Insomnia 
 
Principal Researcher: Grant Forgan, Trainee Clinical Psychologist, University of Glasgow, 
Department of Psychological Medicine. 
 
Introduction 
You are invited to take part in a research study that is being carried out by the University of 
Glasgow. Before you decide, it is important for you to understand why the research is being 
carried out and what is involved. Please take some time to read the following information 
carefully and discuss it with others if you wish. Please contact the researcher if you would like 
more information or if there is anything that is not clear. 
 
What is the purpose of the study? 
 
Sleep difficulties such as insomnia are common with about one in ten adults experiencing a 
problem getting to sleep or staying asleep. People can develop insomnia in childhood or 
adulthood. The purpose of this study is to explore the differences between childhood and adult 
onset insomnia and some psychological factors which may be involved in the development and 
maintenance of these types of insomnia. It is hoped that the findings from this study will add to 
our understanding of these types of insomnia and contribute to the development of more effective 
ways of treating them. 
 
Why have I been chosen? 
 
You are being asked to participate in this research study because you have indicated that you are 
either a good sleeper, who has no trouble sleeping at night, or have been experiencing problems 
with your sleep. It is hoped that altogether, around 90 people will be studied in this project. 
 
Do I have to take part? 
 
It is entirely up to you whether you take part or not. If you decide to take part you will be asked 
to sign a consent form. If you decide to take part you are still free to withdraw at any time 
without giving a reason. A decision to withdraw or not to take part will not affect the standard of 
care you receive and any data collected from you will be destroyed. 
 
What will happen to me if I take part? 
 
If you do not have a sleep problem and decide to take part as a ‘good sleeper’ you will only be 
asked complete a consent form, and some questionnaires which will be posted to you. 
 
If you have a sleep problem and decide to take part you will be asked to meet with the researcher 
to complete a consent form, a set of questionnaires and to take part in an interview. The interview 
will take place at the University of Glasgow Sleep Centre at the Sackler Institute of 
Psychobiological Research, Southern General Hospital. It should last no longer than one hour. 
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(The interview could be conducted by telephone instead at a pre-arranged time if this would be 
more convenient for you. You would then be sent the set of questionnaires to complete and return 
in a postage paid envelope). After the interview you will be asked to complete a sleep diary over 
the following week and then return it to the researcher. You will be asked questions relating to 
sleep quality, the effort you put into getting to sleep and behaviour motivation. There will also be 
some questions about your physical health, mental health and drug/alcohol use. 
 
Will my taking part in this study be kept confidential? 
 
Your participation will be treated with strict confidence. All personal information, such as your 
address and contact details, which is collected about you during the course of the research will be 
kept in a locked cabinet in a locked room (like a medical file) and only the researcher and their 
research supervisor, Professor Colin Espie, Director of the University of Glasgow Sleep Centre 
will have access to it. Most of the information (data) from your assessments will be kept in 
anonymised form and transferred to a password protected computer system that will not have 
your name on it.  
 
It is possible that a result from one of the questionnaires you complete has implications for your 
health or well-being. This could be to do with your mental or physical health and in such an event 
we would let your GP know. Should such concerns arise, we will make every effort to talk with 
you first, prior to reporting. 
 
What are the risks of participation? 
 
Answering some of the questions in the questionnaires and interview may make some people feel 
uncomfortable. You do not have to answer any questions you don’t want to. 
 
Are there any benefits of participation? 
 
There is no direct benefit to you from participating in this study; however, you will receive an 
extensive evaluation of your sleep/sleep disorder at no cost to you. We hope the information 
learned from this study will benefit people experiencing insomnia in the future. 
 
What will happen to the results of the research study? 
 
It is intended that they will be used as part of the researcher’s Doctorate in Clinical Psychology, 
and will also be submitted for publication in a scientific journal. You will not be identified in any 
publication. You will be asked if you wish to receive a summary of the research findings once the 
study has been completed. 
 
Is there someone I can contact to seek independent advice about participating in this study? 
 
You may contact NHS Greater Glasgow and Clyde Research and Development Office on 0141-
211-6313. 
 
Should you wish to participate or require some more information: 
 
Please contact the researcher Grant Forgan on 07989 405 359 or by email at 
g.forgan.1@research.gla.ac.uk  
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Appendix B.6: Participant Consent Form 
 
 
Consent form 
 
Title of research study: Psychophysiological (Adult Onset) Insomnia and Idiopathic (Childhood 
Onset)     Insomnia: The role of self-regulatory behaviour systems. 
 
Principal Researcher: Grant Forgan, Trainee Clinical Psychologist, University of 
Glasgow,     Department of Psychological Medicine. 
 
Please initial each of the boxes 
 
I confirm that I have read and understood the Participant Information Sheet for the above study 
and have had the opportunity to ask questions about the study.  
 
 
 
I understand that participation in the study is voluntary and that I am free to withdraw at any time 
without giving a reason and that all data relating to my participation will be destroyed. 
 
 
 
I understand that all personal information and data relating to my participation in the study will be 
kept confidential.  
 
 
I agree to take part in the study. 
 
 
 
I consent/do not consent (please delete as appropriate) to being contacted in the future regarding other 
sleep research studies and to my personal contact details being retained for this purpose. 
 
 
 
 
Participant Name:          
 
 
Signature:           
 
 
Date:         
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Appendix B.7: Sleep Diary 
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Appendix B.8: Sleep Disorder Assessment Interview 
 
 
University of Glasgow Sleep Centre Assessment Proforma 
 
1. ORIENTATION 
 
Although we a have some information regarding your current sleep problem, it is 
very limited and lacks important detail. Could you explain in your own words the 
nature of your sleeping problem and why you are here today? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2. PERSONAL SLEEP HISTORY 
 
Presentation of Sleep Problem 
a)Pattern 
 
 
 
 
Key Q. What is the pattern of your 
sleep on a typical night? 
 
 
How long does it take you to fall asleep? 
 
 
How often do you wake up? 
 
 
How long are you awake during the 
night? 
 
How much sleep do you get? 
 
 
How many nights a week were like this? 
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b) Quality 
 
Key Q. How do you feel about the 
quality of your sleep? 
 
Is it refreshing? 
 
 
Is it enjoyable? 
 
 
Is it restless? 
 
 
How would you describe it in your own 
words? 
 
 
c) Daytime effects 
 
Key Q. How does your nights sleep 
affect your day? 
 
Do you feel tired? 
 
 
Do you feel sleepy? 
 
 
Do you have problems concentrating? 
 
 
Do you feel irritable? 
 
 
What do you think insomnia does to your 
day? 
 
When are your worst times in the day?  
 
d) Impact on your life 
 
Key Q. How does your insomnia affect 
your quality of life? 
 
 
What consequences does insomnia have 
for you? 
 
What are you not able to do because of 
your insomnia? 
 
How would things be different in your 
life if you overcame insomnia? 
 
 
Development of the Sleep Problem 
 
Key Q. Do you remember how and 
when your poor sleep started? 
 
 
What were the events and circumstances 
then? 
 
What were the important dates and times?  
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How has your sleep changed over time? 
 
 
Anything that has happened that has 
made it worse? 
 
Anything that has happened that has 
made it easier? 
 
 
Lifetime History of the Sleep Problem 
Key Q. Did you used to be a good 
sleeper? 
 
 
How did you sleep as a child? 
 
 
How did you sleep as a teenager? 
 
 
How did you sleep as a younger adult? 
 
 
Were there previous episodes of poor 
sleep? 
 
 
Dates and times? 
 
 
 
Did these past episodes resolve? If so 
how? 
 
 
Family History of Sleep Problems 
Key Q. Do other people in your family 
have problems sleeping? 
 
 
Do either of your parents have sleep 
difficulties (now or in the past) 
 
 
What about brothers and sisters? 
 
 
 
What about the extended family 
including grandparents? 
 
 
Does anyone have problems that are 
similar to your problems sleeping?  
 
 
 
 
General Health and Medical History 
Key Q. Have you generally kept in 
good health? 
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Have you had any major illness? 
 
 
Have any health problems been persistent 
ones? 
 
 
Dates and times? 
 
 
 
Have there been any recent changes in 
your health? 
 
 
 
 
History of Psychological Well-being 
 
Key Q. Are you the kind of person who 
usually copes well? 
 
 
Have you had any psychological 
problems? 
 
 
 
Any problems with anxiety or depression 
or with stress? 
 
 
 
Dates and times 
 
 
 
 
 
Current and Previous Treatments for Insomnia 
 
Key Q. Are you taking anything to help 
you sleep? 
 
 
 
What (if any) medications are you taking 
now to help you sleep? 
 
 
What have you taken in the past? 
 
 
Dates and times? 
 
 
Are you taking anything you have bought 
over the counter? 
 
 
What sorts of things have you tried to do  
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yourself to help you sleep? 
 
 
What have you found has worked and not 
worked? 
 
 
 
 
3. OTHER SLEEP DISORDERS 
 
Sleep Related Breathing Disorder (SBD) 
 
Key Q. Are you a heavy snorer? 
 
 
Do you have interrupted breathing during 
the night? 
 
Does your partner say that you sometimes 
stop breathing? 
 
Do you waken up gasping for breath? 
 
 
Are you excessively sleepy during the 
day? 
 
 
Do you fall asleep in the day without 
wanting to? 
 
 
 
 
Periodic Limb Movements in Sleep (PLMS) and Restless Leg Syndrome (RLS) 
 
Key Q. Do your legs sometimes twitch 
or jerk or can’t keep still? 
 
 
Is it difficult to sleep because of muscle 
jerks? 
 
 
Do you waken out of sleep with sudden 
jerky movements or feeling the need to 
move your legs? 
 
Do you have to get out of bed and pace 
around to get rid of these feelings? 
 
Are you excessively sleepy in the day? 
 
 
 
Circadian Rhythm Sleep Disorders 
a) Delayed Sleep Phase Syndrome (DSPS) 
Key Q. Do you tend to sleep alright but 
at the ‘wrong time’? 
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Can you sleep well enough but only if 
you stay up really late? 
 
 
Are you alert and not sleep until a long 
while after normal bedtime? 
 
 
Are you sound asleep at the normal 
waking time and can sleep on for hours 
more? 
 
 
b) Advanced Sleep Phase Syndrome (ASPS) 
 
Key Q. Do you tend to sleep alright but 
at the ‘wrong time’? 
 
 
Can you sleep well enough but only if 
you go to bed very early? 
 
 
Are you very sleepy if you try to stay up 
until normal bedtime? 
 
 
Do you waken up very early, bright and 
alert and no longer sleepy? 
 
 
 
Parasomnias 
 
Key Q. Do you have unusual 
behaviours associated with your sleep?  
 
 
 
Do you sleepwalk? 
 
 
Do you sleep talk? 
 
 
Do you have confused behavioural 
episodes during the night? 
 
 
Do you have night terrors when you are 
very distressed but not properly awake? 
 
 
Do you grind your teeth in the night?  
Do you sometimes act out your dreams? 
 
 
 
Do you have nightmares? 
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Narcolepsy 
 
Key Q. Do you sometimes just fall 
asleep without warning? 
 
 
Do you have sudden sleep attacks? 
 
 
Is it impossible to resist falling asleep 
during the day? 
 
 
Do you have collapses or extreme muscle 
weakness triggered by emotion? 
 
 
Do you have hallucinations or odd 
sensations when you fall asleep or when 
you waken in the morning? 
 
Do you sometimes feel paralyzed and 
unable to move when you waken from 
your sleep? 
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Appendix B.9: Good Sleeper Questionnaire 
 
The sections marked with ** need to be completed for the purposes of completing the study. 
Your name and address is required if you would like to be sent a summary of the study’s 
findings once it is completed. 
 
 
Name:            
 
Address: 
 
            
 
            
 
            
 
 
**Date of Birth:    
 
**Age:   
 
**Sex:  Male  Female 
 
 
**Sleep Details 
 
Do you currently have difficulties with your sleep?   Yes No 
 
Have you ever had serious or noticeable problems with your sleep in the past? Yes No 
 
If yes; a) How long do you estimate this problem lasted for?      
 
 b) Did the problem resolve itself or did you seek assistance with it from your GP or 
another       source of help? Yes No 
 
 
 
 
Many thanks for providing the above information and for taking part in this 
study. 
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Appendix B.10: Ethics approval letter
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